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INTRODUCTION
Analytical  chemistry may be defined as the science and the art  of 
determining  the  composition  of  materials  in  terms  of  the  elements  of 
composition  contained.  In  this  it  is  of  prime  importance  to  gain  the 
qualitative  and  quantitative  information  of  the  substance  and  chemical 
species i.e., to find out what a substance is composed of and exactly how 
much.
          Analytical  techniques  hold  the  key  to  the  design  development 
standardization and quality control of medical products. They are equally 
important  in  pharmacokinetics  and  in  drug  metabolism  studies  both  of 
which are fundamental to the assessment of bioavailability and the duration 
of clinical response.
          Analytical instrumentation plays an important role in the production 
and evaluation of new products and in the production of consumers and the 
environment.
          Chemical analysis is generally applied in two areas.
 Quantitative analysis  
 Qualitative analysis  
Quantitative analysis:
          The realm of quantitative analysis is to determine how much of each 
of component or of a specified component is present   in the sample.
Qualitative analysis:
          The  realm  of  qualitative  analysis  is  to  determine  the  component 
present in the sample or perhaps confirming its presence (or) absence in the 
sample.
          Highly  specific  sensitive  analytical  techniques  hold the key  to  the 
design,  development,  standardization  and  quality  control  of  medicinal 
products.  Modern  physical  methods  of  analysis  are  extremely  sensitive, 
providing precise and accurate information about the standards of chemicals 
(or) drugs up to a nanogram level.
Spectroscopy2,7  
It is the measurement and interpretation of electromagnetic radiations 
absorbed or emitted when the molecules or atoms or ions of  the sample 
undergo transition from  one energy state (ground state) to another (excited 
state).
UV- Visible spectroscopy:
It involves the measurement of amount of UV radiation absorbed by a 
substance in the solution. The wavelength between 190-390 nm (practically 
200-400  nm)  is  considered  to  be  UV radiations  /  region  Wavelength  is 
defined  as  the  distance  between  any  two consecutive  parts  of  the  wave 
whose vibrations are in phase. For example from the crest of one wave to 
that of the next .Its symbol is λ.Coloured compounds absorb in visible range 
i.e  400 –  800 nm.The  wavelength  at  which  maximum absorbance  takes 
place is called as λmax.    
  The assay of the absorbing substance can be carried out by using :
• Standard absorbtivity value  
• Use of calibration graph  
• Single point standardization  
• Standard absorbtivity value  
This procedure is adopted by official compendia for the stable substance
that have reasonably broad absorption bands and which are practically un 
affected by variation of instrumental parameters .The use of standard A (1% 
1cm) value avoids the need to prepare a standard solution of the reference 
substance in order to determine its absorpitivity.3 
Use of calibration graph:
              In this procedure the absorbance of a number typically (4 – 6) of  
standard solution of the reference substance at concentrations encompassing 
sample concentration are measured and the calibration graph is constructed. 
The concentration of the analide in the sample solution is read from the 
graph as a concentration corresponding to the absorbance of the solution.3 
Single point standardization
This  procedure  involves  the  measurement  of  the  absorbance  of  a 
sample solution and of a standard solution of the reference substance. The 
standard and sample solutions are prepared in the reference manner. Ideally 
of the concentration of the standard solution should be close to that sample 
solution.  The  concentration  of  the  substance  in  the  sample  is  calculated 
using
C test=
 A text  x CStandard
AStandard
Where   Ctest and  CStandard are  the  concentrations  in  the  sample  and 
standard solution Atext and AStandard  are the absorbance of the sample and 
standard solution respectively. The use of UV and visible spectroscopy for 
quantitative analysis employs the method of  comparing the absorbance of 
standards and samples at a selected wavelength .The analysis of mixtures of 
two or more  complements  is  facilitated by activity  of  absorbance.  Other 
applications include measurement of absorption of complexes to establish 
their  composition  of  all  chromogenic  compounds  are  not  suitable  for 
quantitative  measurement  i.e.,  the  choice  of  the  system  and  procedure 
depends largely on the chemistry of the species to be determined.3 
Assay of substances in multi component samples they are :
 Simultaneous Equation method  
 Absorbance ratio method  
 Derivative spectroscopy method  
 Chemical derivatisation method  
 Multi – component mode of analysis  
Simultaneous equation method:
          If a sample contains two absorbing drugs (X and Y) each of which 
absorbs  at  the  λmax  of  the  other.  It  may  be  possible  to  determine  the 
quantity  of  both  drugs  by  the  technique  of  simultaneous  equation  (or) 
Vierodt’s  method.
Criteria  for  obtaining  maximum  precision  based  upon  absorbance 
ratios have been suggested that place limits on the relative concentrations of 
the component of the mixture.
A2
A1
ax2
ax1
                  and              
ay1
ay2
A2
A1
Where 
          ax1, ax2        =        Absorptivities of X at λ1  and λ2
          ay1, ay2         =        Absorptivites of Y at   λ1 and λ2
          A1, A2          =        Absorbances  of the diluted 
                                        Sample at λ1 and λ2
          The  ratio  should lie  outside the  range of  0.1 -  2.0 for  the precise 
determination of (Y and X) two drugs respectively.
          These  criteria  are  satisfactory  only  when  the  λmax of  the  two 
components  is  reasonably dissimilar.  The additional criteria includes that 
the two additional criteria do not interact chemically thereby negating the 
initial  assumption  that  the  total  absorbance  is  the  sum of  the  individual 
absorbance’s.
Derivative spectroscopic method:
          This method involves the conversion of normal spectrum to its first, 
second or higher derivative spectrum the transformations that occur in the 
derivation spectra are understood by reference to an ideal absorption band. 
For the purpose of spectral analysis to relate chemical structure to electronic 
transition and for analysis situations in which mixtures contribute interfering 
absorption. A method  of  manipulating the spectral data called derivative 
spectroscopy  was  developed.  In  this  technique  spectra  are  obtained  by 
plotting the first or higher derivation of absorbance or transmittance with 
respect to wavelength versus wavelength.  Often these plots reverse spectral 
details  which  is  lost  in  an  ordinary  spectrum  In  addition  concentration 
measurement  of  an  analyte  in  the  presence  of  their  interference  can 
something be made easily or more accurately.
Chemical Derivatisation Method:
Indirect spectrophotometic assays are based on the conversion of the 
analyte  by  a  chemical  reagent  to  a  derivative  that  has  different  spectral 
properties.
This method is employed:
If  the  analyte  absorbs  weekly  in  the  uv-region,  a  more  sensitive 
method of assay is obtained by converting the substance to a derivative with 
a more intensely absorbing chromophore.
 The  interference  from  irrelevant  absorption  may  be  avoided  by   
converting the analyte to its derivative which absorbs in the visible 
region where irrelevant absorption is negligible.
 Indirect  spectrophotometric  procedure  is  also  used  to  improve  the   
selectivity  of  the assay of an ultra violet  absorbing substance in a 
sample that contains other UV-absorbing components.
CHROMATOGRAPHY         
Modern  pharmaceutical  formulations  are  complex  mixtures 
containing  one or more therapeutically active ingredients., to a number of 
inert materials like diluents, disintegrants, colourants and flavours in order 
to  ensure  quality  and  stability  of  the  final  product  ,the  pharmaceutical 
analyst must be able to separate the mixtures into individual components 
prior  to  quantitative  analysis  .Amongst  the  most  powerful  techniques 
available  to  the analyst  for  the  separation  of  these  mixtures,  a  group of 
highly efficient methods which are collectively called as chromatography. 
It’s  a  group of  technique  which works  on the principle  of  separation  of 
components of a mixture into individual components,  depending on their 
affinities for the solutes between two immiscible phases. One of the phases 
is affixed bed of large surface area, while the other is a fluid, which moves 
through the surface of the fixed phase. The fixed phase is called stationary 
phase and the other is termed as the mobile phase. Depending on the type of 
chromatography employed the mobile phase may be a pure liquid   or a 
mixture  of  solutions  (eg.buffer)  or  it  may  be  gas  (pure  or  homogenous 
mixture)
Classification of chromatography:-
It  can  be  classified  according  to  the  nature  of  the  stationary  and 
mobile phases
The different types of chromatography are
 Adsorption chromatography  
 Partition  chromatography  
 Ion exchange   chromatography  
 Size exclusion or gel permeation chromatography  
The  modern  instrumental   techniques  GLC,HPLC  and  HPTLC 
provide  excellent  separation  and  allow  accurate  assay  of  very   low 
concentrations of wide variety of substance in complex mixtures.
High Performance liquid chromatography.
HPLC  is  one  among  most  useful  tools  available  for  quantitative 
analysis. Reverse phase chromatography refers to the use of a polar mobile 
phase with a non polar stationary phase in contract to normal phase being 
employed with a non polar mobile phase.
Liquid chromatography is based upon the phenomenon that, under the 
same  conditions,  each  component  in  a  mixture  interacts  with  its 
environment differently from other components. Since HPLC is basically a 
separating technique analysis. It is always used in conjunction with another 
analytical  tool  for  quantitative  and  qualitative  analysis.  The  mode  of 
operation of this system is isocratic. i.e. one particular solvent or mixture is 
pumped  throughout  the  analysis  for  some  determinations  the  solvent 
composition may be altered gradually to give gradient elution.
          The rate of distribution of drugs between stationary and mobile phase 
is controlled by diffusion process,  if diffusion is minimized,  a faster  and 
effective separation can be achieved. The techniques of high performance 
liquid chromatography are so called because of its improved performance 
when compared to classical column chromatography. Advances in column 
technology  high  pressure  pumping  system  and  sensitive  detectors  have 
transformed  liquid  column  chromatography  into  high  speed,  efficient, 
accurate and highly resolved method of separation 
Modes of separation:
In normal phase mode the stationary phase (e.g. silica gel) is polar in 
nature  and  the  mobile  phase  is  non-polar.  In  this  technique  non-polar 
compounds travel faster and are eluted first.  This is because less affinity 
between  solute  and  stationary  phase.  Polar  compounds  are  retained  for 
longer time in the column because more affinity towards stationary phase 
and takes more time to be eluted from the column. This is not advantageous 
in pharmaceutical applications since most of the drug molecules are polar in 
nature and takes longer time to be eluted and detected. Hence this technique 
is not widely used in pharmacy.
Importance of polarity in HPLC:
Polarity is a term that is used in chromatography as an index of the 
ability of compounds to interact with one another. It is applied very freely to 
solutes. Stationary and mobile phase HPLC, the eluting power or solvent 
strength  of  the  mobile  phase  I  mainly  determined  by its  polarity.  If  the 
polarities of stationary phase and the mobile phase are similar, it is likely 
that the interactions of solute with each phase may also be similar, resulting 
in poor separation. Retention of solutes is usually altered by changing the 
polarity of the mobile phase.
Apparatus:2,4,5,6  
Pumps:
Pumps  are  required to  deliver  a  constant  flow of  mobile  phase  at 
pressures ranging from 1 to 550 bar. Mechanical pumps of the reciprocating 
piston  type  give  a  pulsating  supply  of  mobile  phase.  Dual  piston 
reciprocating pumps produce an almost pulse free flow because so that as 
one is filling the other is pumping. Modern injectors are based on injection 
valves which allow the sample at atmospheric pressure to be transferred to 
the high pressure mobile phase immediately before the column inlet. With 
the injector is in the LOAD position, the sample is injected from a syringe 
through a needle port into the loop. The valve lever is then turned through 
600  to  the  INJECT  position  and  the  sample  is  injected  from  a  syringe  
through a needle port, into the loop. The valve lever is then turned through 
600  to the inject position and the sample is swept into the flowing mobile  
phase.  If  an excess  of  sample  is  flushed through the loop in the LOAD 
position, the volume injected is the volume of the loop. Which is typically 
10 – 20 q l  for  analytical  separations  and 0.1ml  for  semi-preparative or 
preparative separations. This complete filling procedure offers the analyst 
the  highest  reproducibility  and  is  capable  of  giving  relative  standard 
deviations of less then 0.2%.
Columns:
HPLC  columns  are  made  of  high  quality  stainless  steel  polished 
internally to a mirror finish. Standard analytical columns are 4-5mm internal 
diameter and 10-30cm in length shorter columns 3-6cm in length containing 
small  particle  size  packing  material  (3-5q  m)  produce  similar  or  better 
efficiencies in terms of the number of theoretical plates about 7000, that 
those of 20cm columns containing 10 q m irregular particles and are used 
when  short  analysis  times  and high throughput  of  samples  are  required. 
Microbore columns of 1-2mm internal advantages of lower detection limits 
and lower consumption of solvent, the latter being important if expensive 
HPLC grade solvents are used. HPLC may also be carried out on the semi-
preparative or preparative scales by using columns of 7-10mm or 20-40mm 
internal diameter respectively.
Packing materials and mobile phases:3 
Many of the packing materials used in HPLC are based on materials 
used  in  classical  column  chromatography.  The  commonly  used  packing 
materials  and  their  associated  solvent  systems  in  each  of  the 
chromatographic modes are
1) Partition HPLC  
2) Adsorption HPLC  
Adsorption HPLC:
Adsorbents  used  in  classical  column  chromatography,  unmodified 
silica has proved to be the most widely used in HPLC. The functional group 
responsible for adsorption is the silanol (Si-OH) group which interacts with 
the  sample  solutes  by  hydrogen  bonding.There  is  therefore  increasing 
retention of solutes with increasing solute polarity. Alumina is used as an 
adsorbent  less  frequently  than  silica,  although  for  some  separations  in 
particular  of  aromatic  substances  and  of  structural  isomers,  greater 
selectivity is obtained with alumina. 
Partition HPLC:
Packing  materials  based  on  silica  are  also  used  in  partition 
chromatography. Early applications of partition HPLC involved coating the 
silica  with  a  polar  liquid  stationary  phase.  Eg.  Ethane-1,2-diol.  Such 
packing materials have now been replaced by silica to which polar phases 
are chemically bonded. Example,
          Si – (CH2)3-O-CH2-CH-CH2
                                           |        |
                                          OH   OH 
          Eg: LiChrosorb Diol
          Si – (CH2)3 –CN                  e.g. Q Bond pak CN
                  Si – (CH2)3 –NH2                e.g. Polygosil NH2.
In  reversed  –phase  partition  HPLC  the  relative  polarities  of  the 
stationary  and  mobile  phase  are  the  opposite  to  those  in  normal  phase 
HPLC, i.e.  the stationary phase is less  polar  than the mobile  phase,  and 
consequently  the  solutes  are  eluted  in  the  order  of  their  decreasing 
polarities.  The  stationary  phase  is  silica,  chemically  bonded  through  a 
siloxane (si-o-si-o) linkage to a low polar functional group. These phases 
are  prepared  by  treating  the  surface  silanol  groups  of  silica  with  an 
organochlorosilane reagent
                       CH3                         CH3
      |                              |
- SI – OH + CI – SI – R  --->  - SI – O – SI – R + HCL 
      |                              |
   CH3                           CH3
Where R      = C6H13 (Hexyl)
                       C8H17 (Octyl)
                       C18H37 (Octadecyl).
Untreated  silanol  groups  may  be  ‘capped’  by  treatment  with 
trimethylchlorosilane to eliminate adsorption effects.
The mobile phase in reversed-phase HPLC generally comprises water 
and  a  less  polar  organic  solvent  modifier.  e.g.  methanol  or  acetonitrile. 
Separations in these systems are considered to be due to different degrees of 
hydrophobicity of the solutes. The less polar solutes partitioning to a greater 
extent into the non-polar stationary phase and consequently being retained 
on the column longer than the more polar solutes. The rate of elution of the 
components  is  controlled by the polarity  of  the organic  modifier  and its 
proportion in the mobile phase. The rate of elution is increased by reducing 
the polarity, e.g. by increasing the proportion of the organic solvent or by 
using  acetonitrile  instead  of  methanol.  The  simple  alteration  of  the 
composition  of  the  mobile  phase  or  of  the  flow rate  allows  the  rate  of 
elution of the solutes to be adjusted to an optimum value and permits the 
separation of a wide range of chemical types.
Detectors:
          The  detection  of  the  separated  components  in  the  eluate  from the 
column  is  based  upon  the  bulk  property  or  the  solute  property  of  the 
individual components.  The most  commonly used detectors in the HPLC 
are.
i. Photometric detectors :
These normally operate in the ultraviolet region of spectrum and are 
the most extensively used detectors in pharmaceutical analysis. They are of 
five principal types :
• Single wavelength detectors  
• Multi-wavelength detectors  
• Variable wavelength detectors  
• Programmable detectors  
• Diode array detectors.  
ii. Fluorescence detectors: 
These  are  essentially  filter  fluorimeters  or  spectrofluorimeters 
equipped  with  granting  monochromators  and  micro  flow  cells.  Their 
sensitivity depends on the fluorescence properties of the components in the 
eluate.
iii. Refractive index detectors:
These are differential refractometers which respond to the change in 
the bulk property of the refractive index of the solution of the component  in 
the mobile solvent system. The sensitivity of the refractive index detector is 
much less than that of specific solute property detectors.
iv. Electrochemical  detectors :         
          These are based on standard electrochemical principles involving 
amperometry  voltammetry  and  polarography.  These  detectors  are  very 
sensitive  for substances that are electroactive.
Validation 8,9,10  
Validation  means  assessment  of  validity  or  action  of  proving 
effectiveness. Method validation is the process of proving that an analytical 
method is acceptable for its intended purpose. For pharamaceutical methods 
guidelines  from  the  united  states  pharmacopeia  (USP),  interenational 
conference on harmonization (ICH) and the food and drug administration 
(FDA) provide a frame work for performing such validations
Parameters used for assay validation.
The validation of  the assay procedure was carried out  as  per  ICH 
guidelines using the following parameters.
Specificity:
Specificity  is  the  ability  to  asses  unequivocally  the  analyte  in  the 
presence  of  components  which  may  be  expected  to  be  present  lack  of 
specificity  of an individual  analytical  procedure may be compensated by 
other supporting analytical  procedures.  For the chromatographic methods 
developing  a  separation  involves  demonstrating  specificity,  which  is  the 
ability  of  the  method  to  accurately  measure  the  analyte  response  in  the 
presence of all potential sample components. The response of the analyte in 
test  mixtures containing the analyte and all  potential  sample components 
(placebo  formulation,  process  impurities,  etc.)  is  compared  with  the 
response of a solution containing only the analyte. Specificity criteria for an 
assay method is that the analyte peak will have baseline chromatographic 
resolution of at least 1.5 from all other sample components. If this cannot be 
achieved the unresolved components  at there maximum expected level  will 
not affect the final assay result by more than 0.5%
Linearity :
                    Linearity  of  an  analytical  procedure  is  its  ability  (within  a 
given range) to obtained test results, which are directly proportional to the 
concentration (amount)  of analyte in the sample.  For assay methods,  this 
study  is  generally  performed  by  preparing  standard  solutions  at  five 
concentration levels. Five levels are required to allow detection of curvature 
in  the  plotted  data  acceptability  of  linearity  data  is  often  judged  by 
examining the correlation and y- intercept of the linear regression line for 
the response versus concentration plot. A correlation coefficient of >0.999 is 
generally  considered  as  evidence  of  acceptable  fit  of  the  data  to  the 
regression line. The y- intercept should be less than a few percent of the 
response obtained for the analyte at the target level.
Accuracy:
                    The  accuracy  of  an  analytical  procedure  expresses  the 
closeness  of  agreement  between the  value  which is  accepted  either  as  a 
conventional  true  value  or  an  accepted  reference  value  and  the  value 
found .The accuracy of a method is the closeness of the measured value to 
the true value for the sample. Accuracy is usually determined in one of four 
ways.
          1.  Accuracy can be assessed by analyzing a sample of known 
concentration and comparing the measured value to the true value.
          2. To compare test results from the new method with results from an  
existing .alternate method that is known to be accurate.
           3. The most widely used recovery study, is performed by spiking 
analyte in blank matrices. For assay methods, spiked samples are prepared 
in  triplicate  at  three  levels  over  a  range  of  50-150%  of  the  target 
concentration. 
           4. The technique of standard additions, which can also be used to 
determine  recovery  of  spiked analyte.  This  approach is  used if  it  is  not 
possible  to  prepare  a  blank  sample  matrix  without  the  presence  of  the 
analyte.
          Accuracy criteria for an assay method is that the mean recovery will 
be 100+2% at each concentration over the range of 80-120% of the target 
concentration.
Range:
             Range of analytical procedure is the interval between the  upper and 
lower  concentration  amounts  of  analyte  in  the  sample  including  these 
concentration  for  which  it  has  been  demonstrated  that  the  analytical 
procedure has  a  suitable  level  of  precision,  accuracy and  linearity.  The 
range  is  determined  using  data  from the  linearity  and  accuracy  studies. 
Range  criteria  for  an  assay  method  is  that  the  acceptable  range  will  be 
defined as the concentration interval over which linearity and accuracy are 
obtained per previously discussed criteria and that yields a precision of 3% 
RSD.
Precision:
                The precision of an analytical procedure express the closeness of 
agreement  between  a  series  of  measurements  obtained  from  multiple 
sampling of the same homogenous sample under the prescribed conditions. 
Precision  of  an  analytical  procedure  is  usually  expressed  the  variance, 
standard deviation or coefficient of variance of a series of measurements. 
The  first  type  of  precision  study  is  instrument  precision  or  injection 
repeatbility. A minimum of 10 injections of one sample solution is made to 
test the performance of the chromatographic instrument. The second type is 
repeatability or intra-assay precision. Intra-assay precision data are obtained 
on one day.  Aliquots of  a homogenous sample,  each of  which has been 
independently  prepared  according  to  the  method  procedure.  from  these 
precision studies, the sample preparation procedure  the number of replicate 
samples to be prepared,  and the  number  of  injections required for  each 
sample in the final method procedure will be set. An example of precision 
criteria for an assay method is that the instrument precision (RSD) will be 
1% and the intra assay precision will be 2%
Detection limit 
          The detection limit of an individual  analyte procedure is the lowest 
amount of analyte in a sample which can be detected but not necessarily 
qualitated  as  an  exact  value.  Detection  limit  based  on  the  standard 
derivation  of the response  and the slope. 
          Detection limit (or) limit of detection may be expressed as,
          
DL= 
3.3
S
σ
Where 
σ = standard deviation of the response
S= slope of the calibration curve (of the analyte)
Quantitation limit:
The quantitation of an analytical procedure is the lowest amount of 
analyte in a sample, which can be quantitatively determined with suitable 
precision and accuracy.
Quantitation limit based on the standard deviation of the response and 
the slope. It can be expressed as,
                                    
QL= 
10
S
σ
          Where 
σ = standard deviation of the response 
S = slope of the calibration curve (of the analyte)
Ruggedness:
The  ruggedness  of  an  analytical  method  is  the  degree  of 
reproducibility  of  test  result  obtained,  the analysis  of  conditions  such as 
different  laboratories,  different  analysis  using  different  instrument,  on 
different  days.  Different  source  of  reagent,  elapsed  assay  times,  assay 
temperature conditions. Ruggedness is a measure of reproducibility of test 
result under the variation in conditions normally expected from analyst to 
analyst. The criteria of the ruggedness is the RSD should be not more than 
2%.
Robustness:
The  robustness  of  a  method  is  its  ability  to  remain  unaffected  by 
small changes in parameter such as percent organic content and pH   of the  
mobile phase, buffer concentration, and temperature and injection volume. 
These  method  parameters  may  be  evaluated  one  factor  at  a  time  or 
simultaneously as part of a factorial experiment. The criteria for robustness 
is the RSD should be not more than 2%.
System suitability testing:
           System suitability testing is an integral part of many analytical  
procedures  the  tests  are  based  on  the  concept  that  the  equipment, 
electronics, analytical operation and samples to be analyzed constitute an 
integral system that can be evaluated as such. Typically the process involves 
making  five  injections  of  a  standard  solution  and  evaluating  several 
chromatographic  parameters  such  as  resolution,  area  %  reproducibility, 
number of theoretical plates and tailing factor.
Retention  time : ( Rt)  
This is the time of emergence of the peak maximum of a compound 
after injection.
Retention volume: (RV) 
The  volume  of  mobile  phase  required  to  elute  one  half  of  the 
compound from the column as indicated by the peak maximum and is given 
by      RV = Rt      x     flow rate
Asymmetry factor (or ) tailing factor (T )
T       =        
Y x
2A
where ,
yx            =        the width of the peak at one twentieth of the peak height.   
A       =        the distance between the perpendicular dropped from the peak 
          maximum and the leading edge of the peak at one twentieth of 
          the peak height.  
The value lies between 0.95 to 1.05.
 
Number of theoretical plates (N )
          N = 5 .54 x  RtW h
2

2
The assessment of performance of efficiency of a column is in terms 
of the number of theoretical plates
            Rt        = retention time
            Wh\2    = width of peak at half height
Resolution (R):
R       =        
2 R t2−R t1
W 2W 1
This  gives  the  resolution  between  the  measured  peaks  on  the 
chromatogram.
Where 
Rt1 and Rt2    = retention time of two component.
Wt1and Wt2 = the respective peak width. Resolution between 
   measured peaks on the chromatogram must be > 1
STATISTICAL PARAMETERS: 
          Statistics consists of a set of methods and rules for organizing and 
interpreting observations.
γ
m
=
=
Σ(X- ) (Y- )X Y
Σ(X- ) (Y- )X Y
Σ(X- )  (Y- )X Y2 2
Σ(X- )X 2
Slope (m)
(σ) = Σ(X- )X 2
n-1
R.S.D (%) = S.D 
X
x 100
Lineanrity coefficient (  γ)
Standard deviation (σ)
Where
Σ            = Sum of observation 
X            = Mean of arithmetic average (Σx/n)
X            = Individual observed value.
x-x          = Deviation of a value from the mean.
N            = Number of observation                  
R.S.D     =Relative standard deviation
Information on Sample, 
Define Separation Goals
Need for Special HPLC Procedure, 
Sample Pretreatment, etc?
Choose Detector and  Detector Settings
Choose HPLC Method, Preliminary Run, 
Estimate Best Separation Conditions
Optimize Separation Conditions
Check for problems (or) 
Requirement for special procedure 
Recover Purified Material Quantitative Calibration Qualitative Method
Validation for Release to laboratory
DEVELOPMENT OF REVERSE PHASE HPLC METHOD6
          “Validation  does  not  make  a  method  good  or  efficient;  it  merely 
demonstrates  that  an  analytical  method  performs  in  accordance  with  the 
claims made for it”.                    
HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY17  
Thin  layer  chromatography  (TLC)  also  know  as  planar  – 
chromatography  or  flat  bed  chromatography  a  multi  stage  distribution 
process.  The  three  chromatography  techniques  TLC,  GLC  or  HPLC  is 
applicable  for  an  analysis  depends  on  several  parameters  solubility  or 
volatility of the sample required separation, efficiency, concentration of the 
analyte, detection limit, cost of analysis, number of sample under analysis 
sample preparation to be separated. TLC as practiced today is in two forms 
some are using it a qualitative tool for separation of simple mixture where 
speed  low  cost  and  simplicity  are  required  others  use  it  as  a  powerful 
separation tool  for  quantitative analysis  with high sample throughput the 
latter now referred to as HPTLC. HPTLC can simultaneously handle several 
samples  even  of  divergent  nature  and  composition  supporting  several 
analysis at a given time HPTLC is the most simple separation technique it 
can be considered a time machine that can speed your work and allows you 
to  do  many  things  at  a  time  usually  not  possible  with  other  analytical 
techniques.
Various steps involved in TLC/HTPC/Planar Chromatography
• Selection  of  TCL/HPTLC  plates  and  srobebt  sample  preparation   
including any clean up and pre- chromatographic derivatization 
• Application of samples  
• Development (Separation)  
• Detection including post-chromatographic  
• Derivatization  
• Quantitation  
• Documentation.  
SCHEMATIC REPRESENTATION OF HPTLC
          Sample and Standard 
Selection of chromatographic
Preparation layer
         Layer Pre – Washing
        Layer Pre – Conditioning
Application of sample and standard
Chromatographic development
            Detection of spots
Scanning and  documentation of 
chromatoplate
Plates:
Pre – coated Plates:
The  precoated  plates  with  different  support  material  (glass, 
aluminium,  plates)  and  with  different  sorbent  layers  are  available  in 
different format and thickness usually plates with sorbent thickness of 100 – 
250μm are using for qualitative and quantitative analysis.
Glass support:
           It is resistant to heat and chemicals easy to handle and always offers 
superior flat and smooth surface for chromatographic work. Disadvantage 
being fragility, relativity high weight additional packing material and higher 
production cost.
Polyester(Plastic) Sheet(0.2 mm thick)
          More economical as they are produced even in rool from unbreakable 
less packing material less shelf space for storage can be cut  to any required 
format   spots  can  cut  and  eluted  charring  reactions  are  possible  but 
temperature should not exceed 120 °.
Aluminium sheet(0.1mm thick)
Aluminium Sheets as support offer the same advantage as polyester 
support but containing high concentration of mineral acids or concentrated 
ammonia, they chemically attack aluminium.
Plate Size:
Pre–coated TLC/HPTLC plates in size of 20 x 20 cm with aluminium 
or polyester support are usually procured. These plates can be cut to size 
and shape good cut edges are obtained any layer which has been loosened as 
a result of cut should be removed by lightly drawing the spatula over the cut 
edge. This is necessary to obtain constant RF values.
Pre- washing of  pre- coated plates:
Pre- washing of plates must be done to at least 1-2 cm longer than the 
subsequent actual chromatographic development .as a result of pre-washing 
signal  to  noise  ratio  is  substantially  low  and  base  lines  are  straighter 
reduction in signal to noise ratio as a result of pre-washing improves the 
limit of detection (LOD) of the procedure.
Methanol is the most commonly employed solvent for pre-washing 
but it cleaning power is not good. It is preferable to carry out pre-washing 
process with mobile phase containing acid or alkali should be avoided as 
they may not be completely removed during subsequent activation mixtures 
of  Chloroform  in  Methanol  (1:1);  Ethyl  acetate  –  Methanol 
(1:1Chloroform:Methanol:Ammonia(90:10:1)  have  been  used  as  solvents 
for  pre-washing.  Methylene-chloride-methanol(1:1)  is  best  suited  for 
removing any impurity one may also try pre-washing with 1% ammonia or 
1% acetic acid in methanol.
Activation of pre-coated plates:
          Freshly opened box of TLC/HPTLC plates usually does not require 
activation However plates exposed to high humidity or kept on hand for 
long time may have to be activated by placing in oven at 110-120 0c for 30 
minutes prior to sample spotting after the plates are removed form pre-wash 
chambers .They should always be dried in vertical position as in horizontal 
position drops of solvent may fall on the plate as a result of condensation. 
Activation at higher temperature and for longer time should be avoided as it. 
It may lead to very active layers and there will be risk of samples being 
decomposed or artifact being formed.
Sample preparation:
          Sample preparation is an important pre-requisite for success of thin 
layer chromatographic separation. The sample preparation procedure is to 
dissolve the dosage form with complete recovery of intact compounds of 
interest and minimum of matrix with a suitable concentration of analytes for 
direct application on the HPTLC plates. Solvent for dissolving the sample 
should  be  non-  polar  and  volative  polar  solvents  are  likely   to  induce 
circular  chromatography  at  origin  for  reversed-phase  chromatography 
usually polar solvents are used for dissolving the sample however such polar 
solvents must wet the sorbent so that sample penetrates the layer uniformly.
Application of sample :
Sample  application  is  the  most  critical  step  for  obtaining  good 
resolution  for  quantification  by  HPTLC.  Use  of  automatic  application 
devices,  is  recommended  for  quantitative analysis  while  using graduated 
capillaries  one must ensure that they fill and empty completely. Usually 
application  of  1-10  µl  volume  for  TLC  and  0.5   -  5µl  for  HPTLC  is 
recommended keeping the size of starting zone down to minimum ; 2-4 mm 
(TLC) and 0.5 1mm (HPTLC) in the concentration range of 0.1 – 1  µg /ml 
for TLC /HPTLC  . 
Mobile phase (MP)
          Mobile  phase  commonly  called  solvent  system  is  traditionally 
selected by controlled process of trial and error and also based on one’s own 
experiment.  Mobile  phase  should  be  chosen  taking  into  consideration 
chemical properties of analytes and the sorbent layer. Use of mobile phase 
containing more than three or four components should normally be avoided 
as it  is  often difficult  to get reproducible ratios of  different  components. 
Various components  of mobile  phase should be measured separately and 
then  placed  in  the  mixing  vessel  laboratories  equipped  with  complete 
HPTLC  system  usually  use  smaller  development  chamber  such  as  twin 
trough  chambers  (10x  10  cm)  where  comparatively  smaller  volumes  of 
mobile phase usually 10-15 ml required. Mobile phase should be measured 
with volumetric pipettes. Different components of mobile phase should be 
first  mixed  in  mixing  vessel  and  then  introduced  into  the  developing 
chamber. Chambers usually containing multi-component mobile phase once 
used is not recommended for re-use and future development work due to 
differential  evaporation  and  adsorption  by  the  layer  and  also  once  the 
chamber I opened each solvent component will evaporate disproportionately 
depending on their volatilities. 
Pre- conditioning (chamber saturation):
Chamber  saturation  has  pronounced  influence  on  the  separation 
profile.  When  the  plate  is  introduced  into  an  unsaturated  chamber,  the 
solvent evaporates form the plate mainly at the solvent front therefore larger 
quantity of the solvent shall be required for a given distance hence resulting 
is increase in Rf values. If the tank is saturated (by lying with filter paper) 
prior to development throughout the chamber. As soon as the plate is placed 
in  such  saturated  chamber  it  soon  gets  pre-loaded  with  solvent  vapours 
hence less solvent shall be required to travel a particular distance resulting 
in lower Rf values 
Development and drying :
          Ascending ,descending, two dimensional horizontal, multiple overrun 
(continuous),  gradient  radial  (circular),  anti-radial  (anti–circular),  multi 
modal (multi  – dimensional) forced flow  planar chromatography are the 
most  common  modes  of  development  After  development  the  plate  is 
removed form the chamber and mobile phase  is removed as completely and 
as quickly as possible. This step should preferably be preformed in fume 
cup  board  to  avoid  contamination  of  laboratory  atmosphere.  The  plates 
should  always  be  laid  horizontally  so  that  while  mobile  phase  migrate 
evenly to the separated substances will migrate evenly to the surface where 
they can be easily detected. Usually analyst may employ hand dryer to faster 
removal of the mobile phase.
Detection and visualization:
          As soon as the development process is complete the plate is removed 
form the chamber and dried to remove the mobile phase completely .the 
zones  can  be  located  by  various  physical,  chemical,  biological–
physiological  methods  there  is  apparently  no  difficultly  in  detecting 
coloured substances  or  colorless  substances  absorbing in  shortwave ultra 
violet  (UV)  region  (254  nm)  or  with  intrinsic  fluorescence  such  as 
Riboflavin,  quinine  sulphate.  The  substances  which  do  not  have  above 
properties  have to  be transferred into detectable  substances  by means of 
chromogenic  or  fluorogenic  reagents  which  are  more  expensive  time 
consuming and complicated. Detection sensitivity depends on the specificity 
for  the  reagent  employed  .Iodine  is  the  universal  detection  reagent. 
Detection under UV light is the first choice and is non – destructive in most 
of the cases and is commonly employed for densitometric scanning.
Validation of HPTLC procedure for pharmaceuticals Analysis:
Selectivity:
          Ability of the developed analytical method to detect analysis analyte 
quantitatively in the presence of other components which are expected to be 
present  in  the  sample  matrix  or  other  related  substances.  Results  are 
expressed as ‘Resolution’ if the expected impurities or related substances 
are available, they should be chromatographed   along with the analyte / 
sample to check the system suitability retention factor,  tailing factor and 
resolution the main parameters  to be observed
Linearity (sensitivity):
                  Ability of the method with in a given range to obtain test result 
in  direct  proportion  to  the  concentration  of  analyte  in  the  sample  – 
calibration curve for the analyte
Precision:
           It provides an indication of random error, results should be expressed 
as relative standard deviation (RSD) or coefficient of variation (10V) 
Repeatability  (precision  on  replication)  Precision  under  same 
conditions (same analyst, same apparatus short interval of time and identical 
reagents) 
     Using the same sample              
 Repeatability of measurement of peak area – RSD > 1% based on   
seven times measurement of same spot 
 Repeatability  of  position  –  RSD  >  2%  based  on  seven  times   
repositioning the instrument after each measurement.
 Repeatability  of  sample  application  –  equal  volume  applied  as   
seven spots  > 3%
Considering that  impurity  limit  of drug substance is usually  rather 
low(sum of impurities usually > 1% acceptable if RSD > 8 .Solutions are 
prepared  form  seven  separately  weighed  amounts  of  same   sample 
determine on the same  chromatoplate using three calibration points within 
the curve.
Reproducibility (precision on comparison)
Precision  under  different  conditions  (different  analyte  different 
laboratory  ,different  days  and reagents  from different  sources)  using  the 
same sample RSD > 10%  within laboratory reproducibility.
Accuracy (trueness)
            Accuracy of an analysis is determined by systematic error involved. 
It is defined as closeness of agreement between the actual (true) value and 
mean analytical value obtained by applying the test method a number of 
times. The accuracy is acceptable if the difference between the true value 
and mean measured value does not  exceed the RSD values obtained for 
repeatability of the method. If the obtained for repeatability of the method. 
If  the  recovery  rate  is  found  to  be  100%  it  implies  that  the  proposed 
analytical method is free from constant and proportional systematic error. A 
blank matrix and known impurities must be matrix and  known impurities 
must  be  available  to  test  the  accuracy  of  the  method  if  the  matrix  or 
impurities are not available it must be recorded.
Ruggedness:
This  is  one of  the mot  important  parameters  for  validation of  any 
analytical  method  following  experiments  are  usually  recommended  to 
evaluate ruggedness of a TLC / HPTLC method. 
a) Sample  preparation:  composition,  quantity  of  solvent,  pH,  shaking   
time temperature and number of extractions to be checked.
b) Sample application: volume applied, spot (shape and size)/ band spot,   
stability.
c) Separation to be performed at least on three different plates from the   
same or different manufacturers
d) Chromatographic conditions chamber saturation, eluent composition,   
eluent  volume,  temperature,  humidity  and  development  distance 
(migration distance)
e) Spot  visualization  :  post  –chromatographic  derivatization,  spraying   
dipping reaction temperature and time 
f) Quantitative evaluation: Drying of plates, detection wavelength used.  
Limit of Detection (LOD)
          Lowest  amount  of  analyte  that  can  be  detected  -  >  10%  of  the 
individual impurity limit if this is not possible then amount of analyte to be 
applied has to be increased LOD is determined on the basis of signal and 
noise ration mean of 15 noise peak areas and their absolute SD values are 
determined. LOD  is the amount of applied sample producing a peak area 
which is  equal  to  the sum of mean blank area  and three  times  standard 
deviation. The ideal detection limit is usually 5-10 folds higher than with 
matrix.
Limit of quantitation (LOQ)
          Lowest amount of analyte which can be quantitatively determined in 
a sample with defined precision and accuracy under stated conditions. LOQ 
>  20%  of  the  individual  impurity.  LOQ–amount  of  applied  sample 
producing a peak area which is equal to sum of mean blank and ten times its 
SD. Alternatively decreasing amount of substance (volume – concentration) 
are applied in triplicate on the same plate and RSD calculated from peak 
area of triplicate samples.  LOQ is determined as smallest quantity of the 
substance for which RSD of the peak area of triplicate sample is either > 5% 
or  when  RSD  for  repeatability  of  the  method  does  not  exceed  for 
repeatability  of  the  method  does  not  exceed  5%  not  greater  than  this 
repeatability value.
Stability:
          Analyte  should  not  decompose  during  development  of  the 
chromatogram and should be stable in solution and on the sorbent for atleast 
30 and 15 mts respectively. The intensity of the spot on the chromatogram 
should be constant for at least 60 min chemical reaction of the solvents and 
their impurities can form artifact which may produce extra spot/peak thus 
leading to false assay values. Evaporation of organic solvent to dryness also 
may  lead  to  formation  of  artifact,  complete  removal  of  organic  solvent 
should be avoided.
REVIEW OF LITERATURE
Ready GKS et al; carried out the derivative spectrophotometric and 
graphical  absorbance  ratio  method  for  simultaneous  estimation  of 
norfloxacin  and  tinidazole  in  two  component  tablet  formulations. 
Norfloxacin has an absorbance maxima at 275 nm and Tinidazole has an 
absorbance maxima at 317.8nm in 10% v/v N,N- dimethylformamide. The 
Beer’s  law is  obeyed in  the  concentration  range  of  0  -24 meug  /ml  for 
Nortloxacin and 0 – 36 meug /m1 for Tinidazole.18  
          Incilay suslu et al., carried out the extractive – spectrophotometric 
determination of ofloxacin  by the Application of bromophenol  blue and 
bromocresol   purple.  A  simple  rapid  and  extractive  spectrophotometric 
methods were developed .These methods were based on the formation of 
yellow  ion-pair  complexes  between  the  basic  nitrogen  of  the  drug  and 
bromophenol  blue  and  bromocresol  purple  as  sulphonphthalein  dyes  in 
phthalate  buffer  pH 3.0 and pH 3.1 respectively .The formed complexes 
were extracted with chlorofrom and measured at 414 nm for ofloxacin – 
bromophenol blue and 408 nm for ofloxacin – bromocresol purple. Beer’s 
law was obeyed in the ranges 0.87 – 17.35 and 0.58 – 14.46 mcg/ml19  .  
          Panzade P.D.et al., carried out a simple spectrophotometric method 
for  simultaneous  quantitative  estimation  of  ofloxacin  and  tinidazole  by 
using  simultaneous  equation  method.  In  0.1N  NaoH  ofloxacin  and 
tinidazole shows λmax at 294 nm and 317nm respectively20  . 
          Shervington  ,L.A.et  al.,  developed  a  rapid  and  reliable  HPLC 
method for the simultaneous separation and quantitation of five quinolones 
antibiotics.  Naildixic  acid  norfloxacin  ,ofloxacin,ciprofloxacin  and 
lomefloxacin..The  calibration  curves  were  linear  over  the  concentration 
range  of  1.20-4.8mg/100  ml  .The  separation  was  performed  on  a 
phenomenx  ODS C18column using an isocratic ion pairing  mobile phase 
consisting  of  35%  (v/v)  aqueous  acetonitrile  together  with 
tetrabutylammonium  acetate  sodium  dodecyl  sulphate  and  citric  acid 
(pH3.4)21  
Liao  et  al.,  carried  out  an  HPLC  method  for  the  quantitative 
determination  of  Chlorhexidine  acetate  in  combination  with  ofloxacin  in 
lotion is reported .The average recovery was 100.64% for Chlorhexidine 
acetate and 99.88% for ofloxacin22  . 
Hopkala – H et al., carried out the derivative UV spectrophotometry 
for the determination of ciprofloxacin, norfloxacin and ofloxacin in tablets23   
Wang -  L  et  al., developed  a  spectrophotometric  method  for  the 
determination of ofloxacin in tablets was described 24  . 
Argekar  –  AP  et  al,  developed  a  Quantitative  determination  of 
lomefloxacin,  ofloxacin  pefloxacin  and  enrofloxacin  in  pharmaceutical 
dosages, bulk drugs and process monitoring of enrofloxacin by HPLC–RP25  . 
Zhang  –  X2  et  al.,  carried  out  the  studies  on  preparation  and 
determination of ofloxacin injection and its stability under light and heat for 
upto 1 year was evaluated using spectrophotometry .ofloxacin injection was 
stable under light and heat for 1 year26  .  
Zhang – H et al., developed a UV spectrophotometric  method for 
the determination of ofloxacin granules by UV spectrometry. Recovery and 
accuracy of  this  method were 98.71 and 0.99% respectively.  The results 
were not different from those obtained using HPLC27  . 
          Mathur  –  SC   et  al.,  carried  out  a  simple  accurate 
spectrophotometric method for the determination of ofloxacin in tablets was 
described28  . 
          Srividya – B et al., carried out a simple, rapid ,selective and precise 
high performance thin layer  chromatographic determination  of  ofloxacin. 
The  samples  were  spotted  on  precoated  silica  gel  60  F254  plates  and 
developed with a mobile phase consisting of n- butanol, methanol, strong 
ammonia and water  (4:1:0.9:1.3).Densitometric  analysis of ofloxacin was 
carried out  at  292nm,  the Rf value for  ofloxacin  was 0.53 .The average 
recovery of ofloxacin was 99.35% at the levels tested30  . 
EV-LD et al., determined the microbiological assay for determination 
of  ofloxacin  injection.  A  simple,  sensitive  and  specific  agar  diffusion 
bioassay  for  the  antibacterial  ofloxacin  was  developed  using  a  strain  of 
micrococcus  luteus  ATCC  9341  as  the  test  organinism.  Ofloxacin  at 
concentration ranging 12-27 mug/ ml could be measured in injection. The 
results  obtained  by  three  methods  were  statistically  analysis  variance 
(ANOVA)  and  the  results  obtained  indicate  that  there  is  no  significant 
difference among these methods31  . 
Zhang  –  SY  et  al.,  determined  the  simultaneous  estimation  of 
ofloxacin  ,ketoconazole  and  dexamethasone  in  Bio-Tai  ointment  by 
HPLC32  . 
          Mashru – RC et al., carried out  the spectrophotometric method for 
the  determination  of  pefloxacin  and  ofloxacin  in  pharmaceutical 
formulations.  It  was  determined  that  the method  is  simple  ,accurate  and 
reproducible   for  the  routine  analysis  of  the  drugs  in  bulk  form and  in 
formulations34  . 
Zhang-  X2  et  al., carried  out  a  first  order  derivative 
spectrophotometric method used for the determination of ofloxacin in gel 
form . Interference of other ingredients could be eliminated. Recovery was 
99.9% with an RSD of 0.7% 35  
Jiang  –  JY  et  al., developed  a  ultraviolet  spectrophotometry  of 
ofloxacin injection.  The wavelength of detection was 293nm. Absorption 
coefficient was 927,and average recovery was 99.9%36  . 
Ertan  –  R   et  al., studied  on  the  quantitative  determination  of 
ofloxacin  ,one  of  the  fluoroquinolone  derivatives.  Quantitative  analysis 
methods,including acidimetry and non-aqueous titration of ofloxacin tablet 
formulations were investigated..UV spectrometry and high pressure liquid 
chromatograpy  were  also  utilized   for  the  determination  of  the  active 
compound in tablet formulations and the sensitivities of the methods were 
compared37  . 
Yin –C et al., carried out the determination of four quinolones by 
high  performance  capillary  electrophoresis  method.  Lomefloxacin 
hydrochloride,  enoxacin,  ciprofloxacin  hydrochloride  and  ofloxacin  is 
described38  . 
Kitade –T et al.,  carried out an easy and sensitive method for the 
quantitative  determination  of  ofloxacin  by  using  solid  substrate  room- 
temperature phosphorimetry on a poly (vinyl alcohol) substrate. The method 
did not require a dry gas flush during the measurement of phosphorescence. 
The phosphorescence intensity of ofloxacin was enhanced using NaoH and 
KI as enhancers. The influence of different conditions such as solution pH 
and concentration of heavy atoms used as the enhancer were studied.39  
Narayana et al; developed and validated the RP – HPLC method for 
the estimation  of nitazoxanide  in bulk Drug and tablets40  .   
I.Sullayman  adagu  et  al; carried  out  the  invitro  activity  of 
nitazoxanide and related compounds against isolates of Giardia intertinalis, 
entamoeba histolytica and trichomonas vaginalis. The activates of the N – 
(nitrothiazolyl)  salicylamide   nitazoxanide  and  its  metabolite  tizoxanide 
were compared with metronidazole invitro in microplates against six axenic 
isolates of Giardia intestinalis. Tizoxanide was eight times more active than 
metronizole  against  metronizole  susceptible  isolates  and  twice  as  active 
against a resistant isolate41  .  
Marcelo donadel malesuik et al., developed a validated stability  - 
indicating LC method for  Nitazoxanide  in pharmaceutical formulations. 
An isocratic LC separation was performed on a phenomenax synergi fusion 
C18 column using a mobile phase of  0.1 %  O – Phosphoric acid solution 
.pH 6.0 Acetonitrile (45:55 v/v )  at a flow rate of 1.0 ml/ min. Detection 
was  achieved with a  photodiode array  detector  at  240 nm.  The detector 
response for Nitazoxanide was linear over the concentration range from 2 to 
100 mg /ml (r=0.9999)42  . 
Salvador namur et al ., carried out the development and validation 
of  a  High  Performance  Thin-layer  Chromatographic  method  with 
densitometry,  for  quantitative  analysis  of  Tizoxanide   (a  metabolite  of 
Nitazoxanide ) in human  plasma. The analyte was extracted from human 
plasma  by  Cation  –  exchange  solid  –  phase  extraction.  In  HPTLC  the 
stationary phase was silica gel 60 f254 and the mobile phase was Toluene – 
Ethyl acetate: acetic acid 6.2 : 13.4:0.4(v/v). The working range was 400 – 
16000ng /ml. The average recovery was 85.5543  . 
Kapse GK et al ; carried out a Spectrophotometric method for the 
Estimation  of  Nitazoxanide  in  pharmaceutical  formulation.  Three  simple 
and sensitive spectrophotometric methods in the visible region have been 
developed. These method are based on the reaction of reduced Nitazoxanide 
with P – dimethylamino benzaldehyde, P-demethylamino – cinnamaldehyde 
and vanillin in acidic conditions to form pink, orange red and orange yellow 
coloured chormogens with absorption maxima at 559 nm ,534.5 nm and 475 
nm respectively. The reduction of Nitazoxanide was carried out with zinc 
granules and 5N hydrochloric acid at room tempature in methanol.  Beers 
law is obeyed in the concentration range of 5 – 25 mg/ml and 10 – 50 mg/ml 
respectively44  . 
Ashoks, Jadhav et al., carried out a validated stability indicating RP-
LC  method  for  nitazoxanide,  a  new  antiparasitic  compound.  The  drug 
substance was subjected to stress conditions of hydrolysis, photolysis and 
thermal  degradation.  The  considerable  degradation  of  nitazoxanide  was 
observed under base and peroxide hydrolysis45  . 
          Lakshminarayana  KV  et  al, developed  and  validated  a 
spectrophotometric  method  for  the  estimation  of  nitazoxanide  in  tablet 
dosage form. Two simple and sensitive visible spectrophotometric method 
(A  and  B)  have  been  developed  for  the  quantitiative  estimation  of 
nitazoxanide.  Methods  were  based  on  the  formation  of  reddish  yellow 
coloured and green coloured chromogens, which were measured at 544nm 
and 715nm repectively46  .  
Alsarra et al., developed a stability-indicating HPLC method for the 
determination  of  montelucast  in  tablets  and  human  plasma  and  its 
application  to  pharmacokinetic  and  stability  studies  .The  intra  day  and 
interday precisions showed coefficients of variations ranged from 5.87% to 
9.60% and from 2.13% to 6.18% at three different levels of concentrations47  . 
Radhakrishna  et  al.,  compared  HPLC  and  derivative 
spectrophotometric   methods   for   the  simultaneous  determination  of 
montelucast  and  loratadine  .HPLC  separation  was  achieved  with  a 
symmetry  C18  column and sodium phosphate buffer (pH 3.7): acetonitrile 
(20:80  v/v)  as  eluent  ,at  a  flow  rate  of  1.0ml/min.UV  detection  was 
performed   at  225nm.In  the   UV   second  –order  derivative 
spectrophotometry.for  the determination   of  loratidine the zero –crossing 
technique  was applied at 276.1nm but for montelucast peak amplitude at 
359.7nm(tangent method) was used48  . 
Liu-L et  al; developed a  stereoselectoive  high performance liquid 
chromatography  with  column  switching  for  the  determination  of 
montelucast (MK-0476) and  its s –enantiomer in human plasma49  . 
Alsarra  et  al; developed  a  spectrofluorometric  determination  of 
montelucast  in  dosage  forms  and  spiked  human  plasma  .The  highest 
fluorescence intensity was obtained in methanol at 390nm using 340nm for 
excitation50   
Amin RD et al; carried the determination of montelucast – 0476 in 
human plasma by liquid chromatography.the  method involves precipitation 
of  protein and reversed – phase  liquid chromatogaphy with fluorescence 
detection. The assay is linear in the range of 30 – 3000 ng /m1-1  of MK – 
0476 and the limit of detection is 5ng m1-1. The interday accuracy values at 
these concentrations are 94 and 104% respectively the absolute recovery of 
MK – 0476 is 99%52  
Alsarra  et  al;  developed  a  voltammetric  determination  of 
montelucast  sodium in  dosage  forms  and human  plasma.It   was  studied 
using  cyclic  voltammetry  ,direct  current  (DCT)  differential  pulse 
polarography (DPP) and alternating current (ACT) polarography. The mean 
% recovery (n=5) was 101.38+/- 3.85 . The number of electrons transferred 
in  the  reduction  process  could  be  accomplished  and  a  proposal  of  the 
electrode reaction was proposed54  . 
Sentuerk-Z et al.,carried out the determination of theophylline and 
ephedrine HCL in tablets by ratio spectra derivative spectrophotometry and 
LC. The first derivative amplitudes at 231.8 and 250.3nm were selected for 
the  assay  of  theophylline  and  ephedrine  .  For  High  performance  liquid 
chromatography mobile phase of Methanol-Water (40:60) with detection at 
217nm.Linearity was obtained in the concentration range of 5-150mug55  . 
Shishoo-CJ  el  al., developed  a  sensitive  HPLC  method  for 
bioavailability  and  bioequivalence  studies  of  theophylline  SR 
formulations.The HPLC method was applied in a 2 way cross over study 
with an 8 day washout period of the bioavailability and bioequivalence in 6 
healthy male volunteers56  . 
Budvari-Barany Z et al., carried out two HPLC methods  and used 
for  the  determination  of  purity  of  caffeine  ,theophylline  and 
theobromine.The  2  systems  enabled  the  detection  of  0.1-0.2%  of  the 
compounds in each other57  . 
Pokrajac-m et al., compared the spectrodensitometric determination 
of theophylline to HPLC, RIA and EMIT procedures .The sample estimated 
were  obtained  from  pediatric  patients  with  drug  concentrations  mainly 
within the therapeutic range. The method was statistically comparable and 
gave good results when compared to HPLC and especially to EMIT but not 
to RIA58  . 
Chen-TM el at., carried the simultaneous determination of ephedrine 
Hcl, phenobarbital and theophylline in regular and sustained action tablets 
using Butabarbital as the internal standard .Recoveries utilizing the method 
ranged from 97.5-100.1% for I,96.3-100% for II and 98.1-100.3% for III in 
conventional tablets59  . 
Culzoni  MJ  el  al., developed  a  chemometrics  assited  UV 
spectroscopic strategies for the determination of theophylline in syrups60  . 
          Elsayed-MAH  et  al., carried  out  the  spectrophotometric 
determination of theophylline formulations.Ampuls were analysed without 
interference from excipients  or  preservatives .A mixture  of  minophylline 
and Phenobarbital in syrup was analysed for both components with good 
accuracy and high reproducibility61  . 
De-Fabrizio –F et al., developed a column chromatography and UV 
spectroscopy.They  were  used  for  the  separation  and  quantitative 
determination of theophylline and etophylline in syrup formulations62  .  
Banner  AS  et  al., carried  out  the  interference  of  drugs  with  the 
determination of  theophylline by the UV spectrophotometric  procedure.It 
was found that the presence of barbiturates ,phenytoin and acetaminophen 
may yield values falsely low by as much as 10 mcg/ml63  . 
          Mirfazaelin  et  al,  developed  a  quantitative  Thin  layer 
chromatography  for  the  determination  of  theophylline  in  plasma.  The 
method  involves  extraction  of  the  drug  and  internal  standard 
(acetaminophen)  by  Chloroform-Isopropanol  (75:25)  followed  by  the 
separation  on  TLC  silica  plates  using  Acetic  acid:Isopropanol:Toluene,
(1:12:6) as the eluting solvent65  . 
Mehdi  ansari  et  al., determined  the  simultaneous  quantitation  of 
theophylline  and  guaifenesin  in  syrup  by  HPLC  ,Derivative  ratio 
spectrophotometry  .For  quality  control  purposes  .The  first  derivative 
method  can  be  applied  only  for  THP  and  depends  on  the  use  of  the 
absorption  spectrum  of  the  binary  mixtures.In  HPLC  method 
methanol:water (40:60v/v) is used as mobile phase. Caffeine was used as 
the internal standard and the substances were detected at 280nm66  . 
EI-Gindy  et  al., developed  the  simultaneous  estimation  of 
diprophylline,phenobarbitone and papaverine hydrochloride by HPLC and 
chemometric  assited spectrophotometric  methods.Mobile  phase consisting 
of 0.02 Potassium di hydrogen phosphate pH 3.5 –acetonitrile (55:45v/v). 
Quantitation was achieved with UV detection at 210nm based on the peak 
area67  . 
Brouwers  -J  et  al., determined  the  intra  aluminal  theopylline 
concentrations after oral intake of an immediate and a slow release dosage 
form.  Human  intestinal  fluids  were  aspirated  from  two  sampling  sites 
(duodenum  and  jejunum)  at  different  time  points  after  oral  intake  of 
theophylline.osmolarity  and  pH  of  the  aspirates  were  mesured  and 
theophylline concentrations were determined by HPLC-UV68  . 
Ku-YR et  al., determined  xanthine  bronchodilators  in  adulterated 
Chinese herbal  preparations by HPLC.A method employing solid –phase 
extraction and HPLC for the extraction and quantitative determination of 5 
bronchodilating xanthines70  . 
Mazzei  et  al., carried  out  the  HPLC  analysis  of  theophylline 
bioequivaiance  study  of  two  sustained  release  formulations  at  steady 
state.An accurate and reproducable isocratic reversed phase HPLC method 
with  UV  detection  is  described  for  the  determination.of  theophylline 
anhydrous in 2 sustained – release formulations71  . 
De – fabrizio – f et al., carried out column chromatography and UV 
spectrometry  for  the  separation  and  quantitative  determination  of 
theophylline(I)  and  elophylline(II)  in  syrup  formulation.  An  aliquot  of 
diluted  syrup  was  pipetted  into  a  chromatography  column  containing  a 
strong  anion  exchange  resin  which  retains  theophylline  and  allows 
etophylline to pass through it. It was subsequently eluted with in Hcl and 
determined  by  difference  spectrometry  at  284nm;etophylline  was 
determined at 272.72  
Scott  –NR  et  al; developed  an  HPLC  method  with  ion  pair 
complexation  is  described  for  the  determination  of  methylxanthine 
metabolites  of  caffeine  and  theophylline  in  urine.  Comparison  of  this 
procedure with direct injection of diluted urine specimens showed the latter 
analysis for the quantitation of the major urinary metabolites76  . 
          
          
AIM OF THE PRESENT WORK
          Antibacterial drugs namely ofloxacin and nitazoxanide are selected 
for  analysis  by  UV  spectrophotometric  method  and  reverse  phase  high 
performance liquid chromatography.  It  is  estimated  by  simultaneous 
equation method as the λmax  of the drug is dissimilar and their absorbance 
ratio lies outside the range 0.1 to 2. It is also estimated by Absorbance ratio 
methods the drugs absorbs at the λmax of the other.
The next objective is to develop and validate a reverse phase high 
performance liquid chromatography which would be simple, rapid, efficient 
and reliable for the analysis of both the drugs in combined dosage form.
          Antiasthmatic drugs namely Montelucast and Theophylline existing 
in  combined  dosage  from  are  selected  for  analysis  by  UV 
spectrophotometric  method  and  High  performance  thin  layer 
chromatography. In UV both simultaneous equation and absorbance ratio 
methods are carried out  as the drugs absorbs at the λmax of the other and the 
ratio of absorbance at any two wavelengths is a constant value independent 
of concentration or path length.
UV-SPECTROPHOTOMETRIC SIMULTANEOUS 
EQUATION METHOD OF OFLOXACIN AND 
NITAZOXANIDE IN COMBINED TABLET 
DOSAGE FORM
PRINCIPLE:
If a sample contains two absorbing drugs (X and Y) each of which 
absorbs at the λmax of the other. It may be possible to determine the quantity 
of  both  drugs  by  the  technique  of  simultaneous  equation  (or)  Vierodt’s 
method.
Criteria  for  obtaining  maximum precision,  based  upon  absorbance 
ratios have been suggested that place limits on the relative concentrations of 
the component of the mixture.
                              A2 / A1         and              ay2 / ay1
                              ax2 / ax1                                                 A2 / A1
Where                   ax1, ax2 = Absorptivities of X at λ1 and λ2
                    ay1, ay2 = Absorptivities of X at λ1 and λ2
A1, A2 = Absorbances of the diluted sample at λ1 and  λ2.
The ratio should lie outside the range of  0.1 – 2.0 for  the precise 
determination of (Y and X) two drugs respectively.
These  criteria  are  satisfactory  only  when  the  λmax of  the  two 
components  is  reasonably dissimilar.  The additional criteria includes that 
two components  do not interact  chemically,  there by negating the initial 
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assumption  that  the  total  absorbance  is  the  sum  of  the  individual 
absorbance’s.
MATERIALS
I. Market Sample  : 
1. ZENFLOX (Discovery mankind pharmaceuticals)  
2.  LABEL CLAIM: 
                                             Ofloxacin   -  200mg 
                                             Nitazoxanide  -   500mg
II. Equipments Used  : 
 ATCO Balance  
 SHIMADZU UV -  spectrophotometer double beam digital  
UV-1700
III. Solvent Used:  
 Methanol AR  
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                       FIXATION OF VARIOUS PARAMETERS
λmax
The wavelength at which maximum absorption takes place  is called 
λmax
Determination of Absorption Maximum (λmax) for Ofloxacin 
Procedure:
          50mg  of  authentic  ofloxacin  sample  was  accurately  weighed  and 
transferred to 50ml volumetric flask, methanol was added, dissolved and the 
volume was made upto 50ml with methanol.
          1ml  of  this  stock  solution  was  pipetted  out  in  to  separate  100ml 
volumetric flask and the volume was made up to 100ml with methanol.
          The absorbance of solution was measured against  solvent blank in 
UV-region of 200-400nm. The λmax was found to be 296nm. This spectrum 
of maximum absorbance is shown in graph-1
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BEER’S LAW PLOT FOR OFLOXACIN
          The  intensity  of  a  beam  of  parallel  monochromatic  radiation 
decreases  exponentially  with  the  number  of  absorbing  molecules.  More 
simply it is stated that the absorbance is proportional to the concentration.
                               Log I0 / It =KC
Beer’s  law  plot  was  constructed  by  measuring  the  absorbance  of 
various concentration of drug against solvent blank.
PROCEDURE
          50mg  of  authentic  ofloxacin  sample  was  accurately  weighed  and 
transferred to 50ml volumetric flask , methanol was added, dissolved and 
the volume was made up to 50ml with methanol.
          From this aliquots of 0.1ml, 0.2ml, 0.3ml,.0.4ml, 0.5ml, 0.6ml, 0.7ml, 
0.8ml, 0.9ml, 1.0ml, was pipetted out in to separate 100ml volumetric flask. 
Then the volume was made upto 100ml with methanol. The absorbance of 
each solution was found out at 296nm against a reagent blank. The readings 
are presented in Table- 1 and graph-2      
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Table – 1
DATA FOR BEER’S LAW PLOT FOR OFLOXACIN
(Linearity)
S.No. Concentration μg/ml Absorption
1 5 0.7670
2 10 0.9535
3 15 1.1145
4 20 1.3694
5 25 1.5447
6 30 1.7698
7 35 1.9423
8 40 2.1425
9 45 2.3944
10 50 2.5645
Linearity Co-efficient (γ ) = 0.9988
Slope (m)                         = 0.04039
Intercept (c)                       =0.5454
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DEVIATIONS FROM BEER’S LAW
          A system is said to obey Beer’s law, where a plot of concentration vs 
absorbance gives a straight line by using  a line of best fit.  When a straight 
line is not obtained ; the system is said to be deviated from Beer’s law.
          For the drug ofloxacin maximum deviation was found  in the 
Concentration range above 50μg/ml.  The readings are presented in 
Table -2 and graph-3
Table 2
DATA FOR DEVIATIONS FORM BEER’S LAW PLOT FOR 
OFLOXACIN
S.No. Concentration μg/ml Absorbance
1. 5 0.7670
2. 10 0.9535
3. 15 1.1145
4. 20 1.3694
5. 25 1.5447
6. 30 1.7698
7. 35 1.9423
8. 40 2.1425
9. 45 2.3944
10. 50 2.5645
11. 55 0.2614
12. 60 0.2648
13. 65 0.2674
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Determination of Absorption Maximum(λmax) for Nitazoxanide
Procedure:
          50mg of authentic nitazoxanide sample was accurately weighed and 
transferred to 50ml volumetric flask and methanol was added, dissolved and 
the volume was made upto 50ml with methanol
1ml of this stock was pipetted out in to separate 100ml volumetric flask and 
the volume was made up to 100ml with methanol
          The  absorbance  of  solution  was measured  against  solvent  bank in 
UV-region  of  200-400  nm.   The  λ  max was  found  to  be  410nm.   This 
spectrum of maximum absorbance is shown in graph-4
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BEER’S LAW PLOT FOR NITAZOXANIDE
          The  intensity  of  a  beam  of  parallel  monochromatic  radiation 
decreases  exponentially  with  the  number  of  absorbing  molecules.  More 
simply it is stated that the absorbance is proportional to the concentration.
                               Log I0 / It =KC
       Beer’s law plot was constructed by measuring the absorbance of various 
concentration of drug against solvent blank.
PROCEDURE
          50mg of authentic Nitazoxanide sample was accurately weighed and 
transferred to 50ml volumetric flask and methanol was added dissolved and 
the volume was made up to 50ml with methanol. 
          From this aliquots of 0.1ml, 0.2ml, 0.3ml, 0.4ml, 0.5ml, 0.6ml, 0.7ml, 
0.8ml, 0.9ml, 1ml, was pipetted out in to separate 100ml volumetric flask. 
Then the volume was made upto 100ml with methanol.  The absorbance of 
each solution was found out at 410nm against a reagent blank.  The readings 
are presented in Table-3 and graph-5
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TABLE-3
DATA FOR BEER’S LAW PLOT FOR NITAZOXANIDE
S.No. Concentration μg/ml Absorbance
1. 5 0.2498
2. 10 0.4836
3. 15 0.7299
4. 20 0.9672
5. 25 1.2094
6. 30 1.4564
7. 35 1.6984
8. 40 1.9394
9. 45 2.1774
10. 50 2.4186
Linearity coefficient γ = 0.9999
Slope (m)                    = 0.04831
Intercept (c)                   =0.00447
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DEVIATIONS FROM BEER’S LAW
          A system is said to obey Beer’s law, where a plot of concentration vs 
absorbance gives a straight line by using a line of best fit. When a straight 
line is not obtained; the system is said to be deviated from Beer’s law.
          For  the  drug,  Nitazoxanide  maximum  deviation  was  found  in  the 
concentration range above 50μg/ml. The readings are presented in Table – 4 
and graph-6 
Table – 4
Data for Deviations from Beer’s law plot for Nitazoxanide
S.No. Concentration μg/ml Absorption
1 5 0.2498
2 10 0.4836
3 15 0.7299
4 20 0.9672
5 25 1.2094
6 30 1.4564
7 35 1.6984
8 40 1.9394
9 45 2.1774
10 50 2.4186
11 55 2.5540
12 60 2.5548
13 65 2.5594
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Preparation of ofloxacin standard solution
          50mg  of  authentic  ofloxacin  sample  is  accurately  weighed  and 
transferred to 50ml volumetric flask and 5ml of methanol was added and 
shaken  until  it  dissolves  and  the  volume  was  made  upto  50ml  with 
methanol.
          From this 1ml was pipetted out in to separate 100ml volumetric flask 
and  the  volume  was  made  up  to  100ml  with  methanol  to  give  a 
concentration of 10μg/ml.
Preparation of Nitazoxanide standard solution 
          50mg of  authentic  nitazoxanide  sample  is  accurately  weighed  and 
transferred to 50ml volumetric flask and 5ml of methanol was added and 
shaken  until  it  dissolves  and  the  volume  was  made  upto  50ml  with 
methanol.    
          From this 1ml was pipetted out in to separate 100ml volumetric flask 
and  the  volume  was  made  up  to  100ml  with  methanol  to  give  a 
concentration of 10μg/ml.
The  absorbance  &  absorptivity  values  are  shown  in  Table-  5a  &5b 
respectively.
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Preparation of sample solution
          Twenty tablets are weighed and average weight was calculated. The 
tablets  are  ground  to  a  fine  powder.  A powder  equivalent  to  200mg of 
ofloxacin  and  500mg  of  nitazoxanide  was  accurately  weighed  and 
transferred to 50ml volumetric flask and 15ml of methanol was added and 
shaken  until  it  dissolves  and  the  volume  was  made  upto  50ml  with 
methanol. This solution was filtered through whatmann filter paper. 
          From this 1ml was pipetted out in to separate 100ml volumetric flask 
and the volume was made up to 100ml with methanol.
          The absorbance of  each solution was found out  at  296nm (λmax of 
ofloxacin) and 410nm (λmax of Nitazoxanide) against a reagent blank.
The analysis data are given in table-6
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Calculation:
          λ1 = 296nm
          λ2 = 410nm
ax1 and ax2 – Absorptivities of ofloxacin at λ1 and λ2
ay1 and ay2 – Absorptivities of Nitazoxanide at λ1 and λ2 
Cx and Cy – Concentration of ofloxacin and Nitazoxanide of
  sample respectively in grams / 100 ml.
A1 and A2 – Absorbance of sample at λ1 and λ2    
Absorptivity (a) = A/bc = Absorbanceb x concentration of substance
Determination of ofloxacin             
Cx = A2 ay1 – A1 ay2ax2 ay1 – ax1 ay2
Determination of Nitazoxanide
Cy = A1 ax2 – A2 ax1ax2 ay1 – ax1 ay2
71
Table-5a
Absorbance values for standard and sample
Wavelength Ofloxacin Nitazoxanide Sample
296
λ1
Ofloxacin
0.1843 (X1) 0.0232 (y1) 1.9746    (A1)
410
λ2
Nitazoxanide
0.0632  (X 2) 0.2541 (y2) 1.6864  A2)
Table-5b
Absorptivity values for ofloxacin and nitazoxanide.
Parameter
Absorptivity at  296nm Absorptivity at 410nm
Ofloxacin Nitazoxanide Ofloxacin Nitazoxanide
*Mean ax1=956.4 ay1=0 ax2= 24.9 ay2=483.6
Absorptivity values are the mean of six determinations. .  ax1 and ax2 
are absorptivities  of ofloxacin at 296 nm, and 410nm, respectively; ay1 and 
ay2 are abxorptivities of  nitazoxanide   at 296nm and 410nm respectively.
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CRITERIA FOR OBTAINING MAXIMUM PRECISION
(A2 / A1)/ (ax2 / ax1)  and (ay2 / ay1)/ (A2 / A1) was found to be 2.49 & 
12.82 respectively.  This ratio should lie outside the range 0.1-2.0 for the 
precise determination.
Table-6
Analysis data of tablet formulations
Parameters
UV-spectrophotometry
Ofloxacin Nitazoxanide
Label Claim 200mg 500mg
Amount found 199.54 mg 496.25mg
*% Drug content 99.77 99.25
        *value for % Drug content are mean of five estimations.
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RECOVERY STUDIES
          To  check the  accuracy  of  the  developed  method  and to  study  the 
interference of formulation additives, analytical recovery experiments were 
carried out by standard addition method at 80, 100 and 120% level. From 
the total amount of drug found the percentage recovery was calculated. The 
results are reported in Table-7.
TABLE-7
Recovery studies
Ofloxacin
Range Amount found Recovery
80% 198.2 mg           99.46%
100% 199.76 mg            99.88%
120% 199.08 mg             99.54%
Nitazoxanide
Range Amount found Recovery
80%       198.2 mg 99.46%
100%       199.76 mg 99.88%
120%      199.08 mg 99.54%
                          *Recovery is the mean of three estimations
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SIMULTANEOUS UV SPECTROPHOTOMETRIC 
ESTIMATION OF OFLOXACIN AND NITAZOXANIDE  IN 
COMBINED TABLET DOSAGE FORM BY ABSORBANCE
RATIO METHOD
PRINCIPLE
This  method depends on the property of  a  substance  which obeys 
Beer’s  law  at  all  wavelengths,  the  ratio  of  absorbance  at  any  two 
wavelengths is a constant value independent of concentration or path length. 
Two different dilutions of the same sample give the same absorbance ratio; 
this ratio is referred to as a ‘Q’ value.
Preparation of Ofloxacin standard solution
          50mg  of  authentic  ofloxacin  sample  is  accurately  weighed  and 
transferred to 50ml volumetric flask and methanol was added and shaken 
until it dissolves and the volume was made upto 50ml with methanol.
          From this 1ml was pipetted out in to separate 100ml volumetric flask 
and the volume was made up to 100ml with methanol.
Preparation of Nitazoxanide standard solution 
          50mg of  authentic  nitazoxanide  sample  is  accurately  weighed  and 
transferred to 50ml volumetric flask and methanol was added and shaken 
until it dissolves and the volume was made upto 50ml with methanol.            
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          From this 1ml was pipetted out in to separate 100ml volumetric flask 
and the volume was made up to 100ml with methanol. The absorbance & 
absorptivity values are shown in table-8a & 8b respectively.
Determination of Iso Absorptive point:
          The standard solutions of Ofloxacin and Nitazoxanide are  scanned 
over  200-400nm.  When  the  graph  was  plotted  with  wavelength  against 
absorbance, the wavelength of equal absorptivity was found at 350nm.   The 
overlain spectra is shown in figure-A
Preparation of sample solution
          Twenty tablets are weighed and average weight was calculated. The 
tablets  are  ground  to  a  fine  powder.  A  powder  equivalent  to  200  mg 
Ofloxacin  and  500mg  of  Nitazoxanide  was  accurately  weighed  and 
transferred to 50ml volumetric flask and methanol was added and shaken 
until it dissolves and the volume was made upto 50ml with methanol. This 
solution was filtered through whatmann filter paper. 
          From this 1ml was pipetted out in to separate 100ml volumetric flask 
and the volume was made up to 100ml with methanol.
          The  absorbance  of  each  solution  was  found  out  at  350nm  (Iso 
Absorptive point) and 410nm (λmax of Nitazoxanide) against a reagent blank.
The analysis value are given in table-9
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Calculation:
          λ1 = 350nm (Iso absorpritive point)
          λ2 = 410nm (λmaxof Nitazoxanide)
ax1 and ax2 – Absorptivities of Ofloxacin at λ1 and λ2
ay1 and ay2 – Absorptivities of Nitazoxanide at λ1 and λ2 
Cx and Cy – Concentration of Ofloxacin and Nitazoxanide
  (Sample) in grams per 100ml
A1 and A2 – Absorbance of sample at λ1 and λ2    
Absorptivity (a) = A/bc = AbsorbanceB x concentration of substance
Determination of Cx and Cy
Cx = Qm – Qy x A1Qx - Qy Ax1
Cy = Qm – Qx x A1Qy - Qx Ax1
Where
Qm =
A2
A1
          
Qx =
ax2
ax1
Qy =
ay2
ay1
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Table-8a
Absorbance values for standard and sample
Wavelength Ofloxacin Nitazoxanide Sample
350 λ1 Iso absorptive point 0.0130(X1) 0.0130 (Y1) 0.1854 (A1)
410 λ2 Nitazoxanide 0.0049 (X2) 0.0967Y2) 0.9984 (A2)
Table-8b
Absorptivity values for Ofloxacin and Nitazoxanide
Parameter
Absorptivity at  350nm Absorptivity at 410nm
Ofloxacin Nitazoxanide Ofloxacin Nitazoxanide
*Mean ax1=65.4 ay1=65.4 ax2= 24.9 ay2=483.6
*Absorptivity values are the mean of six determinations. ax1 and ax2 are 
absorptivities  of Ofloxacin at 350nm, and 410nm, respectively; ay1 and ay2 
are absorptivities of nitazoxanide   at 350nm and 410nm respectively.
Table-9
Analysis data of tablet formulations
Parameters
UV-spectrophotometry
Ofloxacin Nitazoxanide
Label Claim 200mg 500mg
Amount found 201.3mg 501.4mg
*% Drug content 100.67 100.29
*value for % Drug content are mean of five estimations
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RECOVERY STUDIES
          To  check the  accuracy  of  the  developed  method  and to  study  the 
interference of formulation additives, analytical recovery experiments were 
carried out by standard addition method at 80, 100 and 120% level. From 
the total amount of drug found the percentage recovery was calculated. The 
results are reported in Table-10.
Table-10
Recovery studies 
Ofloxacin
Range Amount found Recovery
80% 201.2mg 100.62%
100% 199.5mg 100.27%
120% 201.1mg 100.57%
Nitazoxanide
Range Amount found Recovery
80% 501.4mg 100.28%
100% 501.0mg 100.27%
120% 501.2mg 100.25%
                           *Recovery is the mean of three estimations
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DEVELOPMENT AND VALIDATION OF REVERSE PHASE 
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY OF 
OFLOXACIN AND NITAZOXANIDE IN COMBINED TABLET 
DOSAGE FORM
Instruments:
 Shimadzu liquid chromatograph LC – 10 AT VP  
 Mettler Toledo AG 285 Balance CP-225D  
 DIGISUN-DI-707 pH meter  
 Millipore filter (10.45/   µ m)  
 Whatman filter paper  
 Sonicator  
Reagents and Chemicals
 Acetonitrile  
 HPLC grade water  
 Buffer  
 Methanol  
REFERENCE STANDARDS:
Ofloxacin and Nitazoxanide:
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          These  two reference standards were obtained as gift  samples from 
Discovery  Mankind  Pharmaceuticals.  The  authenticity  and  purity  of  the 
sample was certified by the same.
Sample Tablet brand used      : ZENFLOX    
                                                    Discovery Mankind Pharmaceuticals
Label claim                               :  Ofloxacin  -   200mg
                                                    Nitazoxanide - 500mg
METHOD DEVELOPMENT AND OPTIMIZATION:
SELECTION OF WAVELENGTH:
The known concentration of Ofloxacin and Nitazoxanide were taken and 
dissolved in methanol.   The wavelength were tried at 250nm,
260nm,  270nm  and  the  Peaks  of  the  drugs  were  showing  fronting  and 
tailing.  The peak areas were also found to be minimum.
Finally 280nm were selected for the analysis.
OPTIMIZATION OF CHROMATOGRAPHIC PARAMETAERS
(a) SELECTION OF MODE OF OPERATION:
          As both the drugs were are polar in nature, a RP-HPLC method was 
Proposed.
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(b) SELECTION AND STANDARDISATION OF MOBILE PHASE:
          ZENFLOX is  combination  of  Ofloxacin  200mg  and  Nitazoxanide 
500mg. The method development of Ofloxacin and 
Nitazoxanide  required  adequate  resolution  of  two  drug  peaks  in  the 
chromatogram.
DIFFERENT COMBINATIONS OF BUFFER AND SOLVENTS:
Buffer  (Tetra butyl  ammonium hydrogen sulphate)  and acetonitrile 
(60:40)
Buffer  (Tetra butyl  ammonium hydrogen sulphate)  and acetonitrile 
(50:50)          
Buffer  (Tetra  butyl  ammonium  hydrogen  sulphate)  :  methanol: 
acetonitrile  (10:30:60)
Buffer  (Tetra  butyl  ammonium  hydrogen  sulphate)  : 
methanol:acetonitrile (20:20:60)
Peaks of ofloxacin and Nitazoxanide were well resolved with solvent 
system  Buffer  (Tetra  butyl  ammonium  hydrogen  sulphate):  methanol: 
acetonitrile .(20:20:60) and it is shown in figure-4
SELETION OF FLOW RATE:             
          The Flow rate for Ofloxacin and Nitazoxanide were tried with 0.4ml, 
0.5ml,  and 0.7ml and the peaks of the drugs were showing fronting and 
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tailing with 0.4ml and 0.7ml respectively and finally 1ml per minute was 
selected   for the analysis.                                                                      
PREPARATION OF BUFFER SOLUTION:
Buffer solution was prepared by using 0.6788g of tetra butyl ammonium 
hydrogen sulphate in 200ml of HPLC grade water,filtered through 0.45µ 
nylon membrane and degassed.
PREPARATION OF MOBILE PHASE:
          Mix the Buffer, methanol: and acetonitrile in the  ratio of  20:20:60 
and degass it.  Filtered through 0.45µ membrane.
DILUENT
          Mobile phase is used as diluent.
DETERMINATION OF RETENTION TIME:
(A) STANDARD SOLUTION OF OFLOXACIN:
          Accurately 0.200g of ofloxacin was taken in a 100ml volumetric flask 
and the volume was adjusted to 100ml with mobile phase. 5 ml was taken in 
a separate 50ml volumetric flask and the volume was adjusted to 50 ml with 
mobile phase to get concentration of 200 µg/ml of ofloxacin.  20µl of this 
solution was injected and chromatogram was obtained and it is in shown 
Figure-3.
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STANDARD SOLUTION OF NITAZOXANIDE
          Accurately 0.500g Nitazoxanide  was taken in a 100ml volumetric 
flask and the volume was adjusted to 100ml with mobile phase. 5 ml  was 
taken in a separate volumetric flask of 50ml and the volume was adjusted to 
50ml with mobile phase to get a concentration  of 500 µg/ml. 20µl of this 
solution was injected and the chromatogram was recorded and shown in 
Figure-2
(C) PREPARATION OF MIXED STANDARD SOLUTION:
0.200g of ofloxacin and 0.500g of Nitazoxanide was transferred into a 
100ml dried volumetric flask.  The compounds were first dissolved in 20ml 
of mobile phase and it was sonicated.  Then the volume was adjusted to 
100ml with mobile phase. From the stock solution 5ml was transferred to a 
50ml volumetric flask and the volume was adjusted to 50ml with mobile 
phase to get  a concentration of 200µg/ml of Ofloxacin and 500µg/ml of 
Nitazoxanide.  20  µl   of  the   resulting  solution  was  injected  and 
chromatogram was recorded shown in Figure-4.
84
FIXED CHROMATOGRAPHIC CONDITIONS:
INSTRUMENT              : Shimadzu liquid chromatograph
                                         LC-10 AT VP    
COLUMN                       : C18 
WAVELENGTH            : 280nm
TEMPERATURE           : Ambient temperature.
FLOW RATE                  : 0.5ml/min
INJECTION VOLUME  : 20µl.
MOBILE PHASE           : Buffer (Tetra butyl ammonium hydrogen 
   sulphate ): methanol and acetonitrile.(20:20:60)
RETENTION TIME       : 4.67 min for ofloxacin 7.77 min 
  for nitazoxanide.
QUANTITATIVE DETERMINATION OF THE DRUGS BY USING 
THE DEVELOPED METHOD
Sample                  :         Ofloxacin and Nitazoxanide
Label Claim           :         Ofloxacin – 200mg
                                        Nitazoxanide -500mg
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METHOD:
          Twenty  tablets  were  weighed  and  powdered.   Average  weight 
(1.3595) of sample tablet ZENFLOX (equivalent to 200mg of Ofloxacin and 
500mg of Nitazoxanide ) was taken into 100ml dried volumetric flask.  The 
powder  was  first  dissolved  in  20ml  of  mobile  phase  and  sonicated  and 
finally the volume was adjusted to 100ml with mobile phase.  From this 
solution  5ml  was  transferred  to  50ml  volumetric  flask  and  volume  was 
adjusted to 50ml with mobile phase to get a concentration of 200µg/ml of 
Ofloxacin and 500µg/ml of Nitazoxanide. 20µl of the solution was injected 
and the chromatogram obtained is shown in Figure 5
          The  amount  of  Ofloxacin  &  Nitazoxanide  present  in  the  tablet 
formulation was calculated by comparing the peak area of the standard and 
reports are given in Table-8
Amount of drug present in the tablet:
Sample area
Standard Area
x Standard dilution
Sample dilution
x Potency
100
x Average weight
Percentage purity  =        Amount presentLabel claim x 100
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Table -11
Quantitative Estimation
S. No. Brand Name Content Label 
Claim 
(mg)
Peak area Amount 
present 
(mg)
Percent 
Purity% 
w/v
1. ZENFLOX
ofloxacin 200mg 9563.4884 201.04 100.20%
Nitazoxanide 500mg 5917.5990 12.66 101.281%
Acceptance critearia: 98-102%w/v
Assay for ofloxacin:
Amount Present = 
9563.4884
X
201.0
X
99.87
X 1359.5= 201.04mg10093.2956
1286.
2
100
% Label Claim 
 201.04 X 100 = 100.20 %200
                    
Assay for nitazoxanide:
Amount Present = 
5917.599
0 X
500.1
0 X
99.87
X 1359.5 = 499.71 mg6251.478
3
1286.
2
100
% Label Claim =
499.71 X 100 = 99.94%
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VALIDATION
          Validation  of  an  analytical  method  is  a  process  to  establish  by 
laboratory studies that the performance characteristics of the method meet 
the  requirements  for  the  intended  analytical  application.   Performance 
characteristics are expressed in terms of analytical parameters.
Design of experiment:
Typical analytical parameters used in assay validation are,
 Specificity  
 Linearity and range  
 Limit of quantification  
 Limit of detection  
 Accuracy  
 Precision  
- System precision  
- Method precision  
 Robustness  
 Ruggedness  
 System suitability studies  
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- Resolution  
- Number of theoretical plates  
- The tailing factor.  
SPECIFICITY
          The  specificity  of  an  analytical  method  is  its  ability  to  measure 
accurately and specifically the analytes in the presence of compounds that 
may be expected to be present in the sample matrix.
Determination:
          The specificity of the analytical method was determined by injecting 
the placebo solution under the same experimental conditions as the assay.
Preparation of placebo:
          Placebo  is  prepared  by  mixing  all  the  excipients  without  active 
ingredients.
Procedure:
 225mg  placebo  was  accurately  weighed  and  transferred  into  a   
25ml volumetric flask and the volume was made to 25ml with the 
mobile  phase.  The solution was filtered through Millipore filter 
paper  and  degassed.   20µl  of  this  solution  was  injected  and 
chromatogram was recorded and shown in Figure-6
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 200mg  Ofloxacin  and  500mg  Nitazoxanide  were  weighed  and   
transferred  into  a   100ml  volumetric  flask  and  volume  was 
adjusted to 100ml with mobile phase.  Further 5ml of the solution 
was  taken  and  the  volume  was  made  upto  50ml  to  get  a 
concentration of 200µg/ml Ofloxacin & 500µg/ml Nitazoxanide. 
To this solution 90mg of placebo was added and it was sonicated, 
filtered through a Millipore filter paper .20µl of this solution was 
injected,  chromatogram  was  recorded  and  shown  in  Figure.-7. 
The mixed  standard  solution  was also  injected  without  placebo 
and it was recorded and shown in Figure -8 and the reports are 
shown in Table-12 &13
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Table-12
Specificity for Ofloxacin
S.No. Sample Area obtained
1. Standarad             10093.2956
2. Standard+Placebo 10039.6397
3. Placebo 0
Table-13
Specificity for Nitazoxanide
S.No Sample Area obtained
1. Standarad   6251.4783
2. Standard+Placebo 6200.3386
3. Placebo 0
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LINEARITY AND RANGE:
          Linearity  of an analytical method is its ability to elicit test result that 
are directly proportional to the concentration of analyte in  samples within a 
given range.
Determination:  
          The  linearity  of  the  analytical  method  was  determined  by 
mathematical treatment of test result obtained by analysis of samples with 
analyte  concentrations  across  the  claimed  range.   Area  was  plotted 
graphically as a function of analyte concentration.  Percentage curve fitting 
was calculated.
Method:
Preparation of mixed standard stock solution:
          Accurately weighed 200mg Ofloxacin  and 500mg of Nitazoxanide 
were transferred in  to a 100ml of standard flask and it was dissolved with 
mobile phase and the volume was made upto 100 ml with mobile phase. 
From  the  resulting  solution,4,  4.5,  5,  5.5,  6ml  were  transferred  into  5 
different 50ml volumetric flask.  The volume was made with mobile phase 
to get a final  concentration of 160.8, 180.9, 201.0, 221.1, 242.5µg/ml of 
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ofloxacin  400,450,  500,550,  600µg/ml  of  Nitazoxanide.  20µl  of  the 
resulting solution was injected and chromatogram was recorded.
The  chromatograms  of  ofloxacin  and  Nitazoxanide  are  shown  in 
Figure 9 - 13
Acceptance Criteria
 Correlation coefficient should not be less than 0.99  
The   linearity  datas  and  analytical  performance  parameters  of 
ofloxacin and nitazoxanide are shown in Table-14- 16 and calibration curve 
are shown in graph – A and B
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Table-14
LINEARITY DATA
OFLOXACIN
S.No. Concentration(µg/ml) Peak Area
1. 160.8 8248.9069
2. 180.9 9103.6437
3. 201.0 10119.4923
4. 221.1 11246.5845
5. 242.5 12475.5709
Table-15
NITAZOXANIDE
S.No. Concentration(µg/ml) Peak Area
1. 400 5279.7606
2. 450 5539.6733
3. 500 5843.0991
4. 550 6154.6587
5. 600 6485.6500
Table-16
ANALYTICAL PERFORMANCE PARAMETERS
S. 
no. Drug name
Linear 
dynamic 
range(µ/ml)
Correlation 
coefficient Slope Intercept
1. Ofloxacin (160.8-242.5) 0.9981 52.068 -237.242
2. Nitazoxanide (400-600) 0.9990 6053.5285 2762.8040
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ACCURACY
          The accuracy of an analytical method is the closeness of the results 
obtained by that method to the true value.  Accuracy may often be expressed 
as percent recovery by the assay of known added amount of analyte.
Determination:
          The accuracy of the analytical method was determined by applying 
the method to the analysed samples to which known amounts of analyte had 
been  added.   The  accuracy  was  calculated  from the   test  results  as  the 
percentage of analyte recovered by the assay.
Acceptance criteria:
Percentage recovery should be within 98-102%
PROCEDURE:
Mixed standard stock solution 2ml  and sample  stock solution  2ml 
were mixed together in 50 ml volumetric flask and the volume was made 
upto 50ml with mobile phase to get 80% range. Similarly 100% and 120% 
range  was  prepared.  20µl  of  this  solution  was  injected  three  times  and 
chromatograms were shown in Fig. 14 to 22 and values in table 17 and 18
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Table-17
Recovery Study of ofloxacin.
S.No. RANGE Area obtained
Amount 
Recovered(mg)
% 
Recovery
1. 80%
7620.3121 200.2 100.11
7590.2365 199.4 99.72
7602.4132 199.7 99.88
2 100%
9546.9764 200.6 100.33
9558.0072 200.8 101.42
9566.8988 201.1 100.55
3 120%
11272.7721 197.4 98.73
11524.9356 201.8 100.94
11289.2563 197.7 98.88
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Table-18
Recovery Study of Nitazoxanide
S.No. RANGE Area obtained
Amount 
Recovered(mg)
% 
Recovery
1. 80%
4755.4487 501.8 100.37
4725.5896 498.1 99.74
4698.5682 495.1 99.17
2 100%
5947.2235 502.1 100.42
5926.2385 500.3 100.06
5888.5844 497.1 99.43
3 120%
7151.5948 503.15 100.63
7086.4323 503.15 99.71
7114.9244 500.55 100.11
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PRECISION
          Precision of an analytical method is the degree of agreement among 
individual test results when the procedure is applied repeatedly to multiple 
sampling  of  a  homogenous  sample.   Precision  of  analytical  method  is 
usually expressed as the standard deviation and relative standard deviation.
Determination:
          The precision of the analytical method was determined by assaying 
sufficient number of sample and relative standard deviation was calculated.
          The  precision  of  the   instrument  was  determined  by  assaying  the 
samples consecutively, number of time and relative standard deviation was 
calculated.
Acceptance Criteria:
          The relative standard deviation   should be with in 2%
SYSTEM PRECISION :
Procedure:
          Accurately weighed 200mg of ofloxacin and 500mg of Nitazoxanide 
were transferred  into a  100ml   standard  flask  and it  was  dissolved with 
mobile phase.  From the resulting solution 5ml was transferred into 50ml 
volumetric flask. The volume was made up with mobile phase to 50ml.
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          The  system  precision  was  evaluated  by  measuring  6  successive 
injection of 20µl of standard solution.  The peak response were measured 
from the chromatogram shown in Figure 23-28 and system precision data 
area shown in Table-19& 20.
Method Precision:
Procedure
Twenty tablets were weighed and powdered.  Average weight (1.3595) of 
sample  tablet  ZENFLOX (equivalent  to 200mg of Ofloxacin and 500mg 
Nitazoxanide hydrochloride) was taken into 100ml dried volumetric flask. 
The powder was first dissolved in 20ml of mobile phase and sonicated and 
finally the volume was adjusted to 100ml with mobile phase.  From this 
solution  5ml  was  transferred  to  50ml  volumetric  flask  and  volume  was 
adjusted to 50ml with mobile phase to get a concentration of 200µg/ml of 
Ofloxacin and 500µg/ml of Nitazoxanide. 20µl of the solution was injected 
and  the  chromatogram  obtained  is  shown  in  Figure  29-34  and  method 
precision data are shown in table 21-23
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Table-19
System Precision data
S.No. Area of Ofloxacin Area of nitazoxanide
1. 10039.6397 6200.3386
2. 10066.1488 6344.9496
3. 10111.2275 6272.8360
4. 10093.2956 6251.4783
5. 10119.4923 6256.6252
6. 10124.3483 6263.4962
MEAN 10092.3587 6264.9539
S.D 33.4147 46.668
%RSD 0.3310 0.7449
Table-20
Relative 
Standard 
Deviation
ofloxacin Nitazoxanide
Acceptance
Criteria
0.3310 0.7449 2%
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Table -21 Method  Precision of Ofloxacin
S.No. Area Obtained Assay value in(mg) %  Label claim w/v
1. 9536.4994 200.4 100.23
2. 9546.9764 200.6 100.34
3. 9558.0072 200.9 100.46
4. 9566.8988 201.0 100.50
5. 9524.2345 200.2 101.10
6. 9521.9143 200.1 100.08
MEAN 100.28
STANDARD DEVIATION 0.1784
RELATIVE STANDARD DEVIAION 0.1779
Table-22 Method Precision  of Nitazoxanide
S.No. Area Obtained Assay value in(mg) %  Label claim w/v
1. 5910.4990 499.0 99.80
2. 5947.2235 502.1 100.42
3. 5926.2383 500.3             100.06
4. 5888.5844 497.1 99.43
5. 5898.9423 498.0 99.60
6. 5954.9132 502.7 100.55
MEAN 99.97
STANDARD DEVIATION 0.04075
RELATIVE STANDARD DEVIAION 0.04076
Table-23 Method Precision report for Ofloxacin  and Nitazoxanide 
Relative 
Standard
Deviation
Ofloxacin Nitazoxanide
Acceptance
Criteria
0.1779 0.04076 2%
Limit of detection (LOD)
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          It is the lowest amount of analyte in a sample that can be detected  but 
not  necessarily quantities  as an exact value  under  the stated, experimental 
conditions.  The detection limit is usually expressed as the concentration of 
analyte.
It is given by
L.O.D= 3.3 x σ
                 m
          σ = standard deviation of the response
          m= slope of the calibration curve
TABLE-24
LIMIT OF DETECTION
DRUG STANDARD DEVIATION SLOPE L.O.Dμg/ml
OFLOXACIN 32.1946 52.068 2.040
NITAZOXANIDE 0.0791 6053.5285 0.0000431
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Limit of Quantitation:
          The Quantitation limit of an analytical procedure is the lowest amount 
of analyte which can be Quantitatively determined with suitable Precision 
and Accuracy. 
It is  given by 
L.O.Q = 10xσ
                  m
                    
σ = standard deviation of the response
                    m= slope of the calibration curve
TABLE-25
LIMIT OF QUANTITATION
DRUG STANDARD DEVIATION SLOPE
L.O.Q 
μg/ml
OFLOXACIN 32.1946 52.068 6.183
NITAZOXANIDE 0.0791 6053.5285 0.0001306
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RUGGEDNESS
          The Ruggedness of an analytical method is degree of reproducibility 
of test result obtained by the analysis of the same sample under a variety  of 
normal  test  condition,  such  as  different  laboratories,  different  analyst, 
different  instruments,  different  lots  of  reagents,  different  elapsed  assay 
times, different assay temperature, different days, etc.
          Ruggedness is normally expressed as the lack of influence on test 
result of operational and environmental variables of the analytical method.
Determination:
          The ruggedness of an analytical method was determined by analysis 
of aliquots from homogeneous lots by different analysts using operational 
and  environmental  conditions  that  may  differ  but  were  still  with  in  the 
specified  parameters  of  the assay.   The degree of  reproducibility  of  test 
result  was  then  determined  as  a  function  of  the  assay  variables.   This 
reproducibility was assayed under normal conditions to obtain a measure of 
the ruggedness of analytical method.
          The assay of ofloxacin & Nitazoxanide  were performed in different 
conditions like different analyst on different days.
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Method:
The   standard  and  sample   solutions  were  prepared  by  different 
analysts  on  different  days  and  the  resulting  solution  were  injected  and 
chromatograms are recorded and  shown in Figure 35-42 and ruggedness of 
the  method and report of Ofloxacin & Nitazoxanide are shown in Table 26.
Table-26
RUGGEDNESS
Analyst
Date
Amount Found %purity
Ofloxacin Nitazoxanide Ofloxacin Nitazoxanide
I 26Nov
 2007
200.28 500.55 100.14 100.11
II 26nov 
2007
198.46 497.40 99.23 99.48
I 27Nov 
2007
198.12        502.00 99.06 100.40
II 27Nov 
2007
197.50 494.60 98.50 98.92
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ROBUSTNESS
Robustness  of  an  analytical  method  is  measure  of  its  capacity  to 
remain unaffected by small but deliberate variations in method parameters 
and provides an indication of its reliability during normal usage.
Determination:
          The robustness of an analytical method was determined by analysis of 
aliquots from homogenous lots by differing physical parameters that may 
differ but were still within the specified parameter of the assay for example 
change in physical parameters like flow rate and lambda max.
Method:
Standard solution preparation:
          200mg Ofloxacin and 500mg Nitazoxanide were transferred into a 
100ml volumetric flask, volume was adjusted to 100 ml with mobile phase. 
Further 5ml of the solution was taken and the volume was made upto 50ml 
to  get  a  concentration  of  200µg/ml  of  ofloxacin  and  500µg/ml  of 
nitazoxanide.
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Sample preparation:
          Twenty  tablets  were  weighed  and  powdered.   Average  weight 
1.3595g of sample tablet ZENFLOX (equivalent to 200mg ofloxacin and 
500mg ) was taken into 100ml dried volumetric flask.  The powder was first 
dissolved in 20ml of mobile phase, sonicated and finally the volume was 
adjusted  to  100ml  with  mobile  phase.   From  this  solution  5ml  was 
transferred in to 50ml volumetric flask and volume was adjusted to 100ml 
with  mobile  phase.   20µl  of  this  solution   was  injected   and individual 
chromatograms were recorded and they are shown in Figure 43-58 and datas 
are shown in Table-27-34.
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Table 27
Chromatographic condition:- change in flow rate (0.4ml/min)
Change in flow rate 0.4 ml/min
Column C18
Wave length 280nm
Temperature Ambient25o c  
Injection Volume 20µl
Table 28
Change in flow rate (0.4ml/min)
S.No. Drug Average Standard Area
Average 
Sample 
Area
% Purity 
w/v
1. Ofloxacin 10079.2339 9646.305
6
101.53%
2. Nitazoxanide 6238.1923 5953.548
9
100.74%
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Table 29
Chromatographic condition:- change in flow rate (0.6ml/min)
Change in flow rate 0.6ml/min
Column C18
Wave length 280nm
Temperature Ambient25o c  
Injection Volume 20µl
Table 30
Change in flow rate (0.6ml/Min)
S.No. Drug Average
Standard Area
Average
Sample 
Area
% Purity 
w/v
1. Ofloxacin    10059.4621 9836.3404 101.62%
2. Nitazoxanide     6372.9144 5980.4439 99.05%
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Table 31
Chromatographic condition:- change in  Lambda Max -282nm
Column C18
Wave length 282nm
Temperature Ambient25o c  
Injection Volume 20µl
Flow rate 0.5ml/min
Table -32
Change in Lambda Max-282nm
S.No. Drug Average Standard Area
Average 
Sample 
Area
% Purity 
w/v
1. Ofloxacin 10083.0568 9664.7177 101.68%
2. Nitazoxanide 6522.9706 6120.1818 99.04%
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Table - 33
Chromatographic condition:- change in Lambda Max -278nm
Column C18
Wave length 278nm
Temperature Ambient25o c  
Injection Volume 20µl
Flow rate 0.5ml/min
Table - 34
Change in Lambda Max-278nm
S.No. Drug Average Standard Area
Average 
Sample 
Area
% Purity 
w/v
1. Ofloxacin 10103.7055 9694.6796 101.79%
2. Nitazoxanide 6604.9728 6029.0529 101.15%
111
SYSTEM SUITABILITY PARAMETERS
          System  suitability  testing  is  an  integral  part  of  many  analytical 
procedures.  The test is based on the concept that the equipment, electronics, 
analytical operation and sample to be analysed constitute an integral system 
that  can  be  evaluated  as  such.   System suitability  test  parameters  to  be 
established  for   a  particular  procedure  depend on the  type  of  procedure 
being validated.
Method:
          A solution of 200µg/ml of ofloxacin and 500µg/ml of Nitazoxanide 
were prepared by diluting with  mobile phase and same was injected and a 
chromatogram was recorded and they are shown in Figure 59 and system 
suitability report are shown in the following 
Table - 35
System suitability parameters
S.No. Parameters ofloxacin nitazoxanide
1. Theoretical plates 12,082.1306 8,361.6466
2. Tailing factor 1.00 1.00
3. Resolution 6.2
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UV-SPECTROPHOTOMETRIC SIMULTANEOUS 
EQUATION METHOD OF MONTELUCAST 
AND THEOPHYLLINE IN COMBINED 
TABLET DOSAGE FORM
PRINCIPLE
If a sample contains two absorbing drugs (X and Y) each of which 
absorbs at the λmax of the other. It may be possible to determine the quantity 
of  both  drugs  by  the  technique  of  simultaneous  equation  (or)  Vierodt’s 
method.
Criteria  for  obtaining  maximum precision,  based  upon  absorbance 
ratios have been suggested that place limits on the relative concentrations of 
the component of the mixture.
A2
A1
ax2
ax1
        and    
ay1
ay2
A2
A1
Where 
          ax1, ax2        =        Absorptivities of X at λ1  and λ2
          ay1, ay2         =        Absorptivites of Y at   λ1 and λ2
          A1, A2          =        Absorbances of the diluted 
                                        Sample at λ1 and λ2
The  ratio  should  lie  outside  the  range  of  0.1–2.0  for  the  precise 
determination of (Y and X) two drugs respectively.
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These  criteria  are  satisfactory  only  when  the  λmax of  the  two 
components  is  reasonably dissimilar.  The additional criteria includes that 
two components  do not interact  chemically,  there by negating the initial 
assumption  that  the  total  absorbance  is  the  sum  of  the  individual 
absorbance’s.
MATERIALS
I. Market Sample
1. ZOMONT-THEO (Panacea biotech)  
2.  LABEL CLAIM: 
                                             Montelucast   -  10mg 
                                             Theophylline  -   200mg
II. Equipments Used
 ATCO Balance  
 SHIMADZU UV -  spectrophotometer double beam digital UV-1700  
III. Solvent Used
 Methanol AR  
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FIXATION OF VARIOUS PARAMETERS
λmax
       The wavelength at which maximum absorption takes place is called λmax
Determination of Absorption Maximum (λmax) for Montelucast 
Procedure:
          100mg of authentic montelucast sample was accurately weighed and 
transferred to 50ml volumetric flask, methanol was added, dissolved and the 
volume was made upto 50ml with methanol.
          5ml  of  this  stock  solution  was  pipetted  out  in  to  separate  100ml 
volumetric flask and the volume was made up to 100ml with methanol.
          The absorbance of solution was measured against  solvent blank in 
UV-region of 200-400nm. The λmax was found to be 344nm. This spectrum 
of maximum absorbance is shown in graph-7
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BEER’S LAW PLOT FOR MONTELUCAST
          The  intensity  of  a  beam  of  parallel  monochromatic  radiation 
decreases  exponentially  with  the  number  of  absorbing  molecules.  More 
simply it is stated that the absorbance is proportional to the concentration.
Log 
I o
I t
        =       KC                              
Beer’s  law  plot  was  constructed  by  measuring  the  absorbance  of 
various concentration of drug against solvent blank.
PROCEDURE
          100mg of authentic montelucast sample was accurately weighed and 
transferred to 50ml volumetric flask , methanol was added, dissolved and 
the volume was made up to 50ml with methanol.
          From this aliquots of 2.5ml, 3ml, 3.5ml,.4ml, 4.5ml, 5ml, 5.5ml, 6ml, 
6.5ml, 7.0ml,7.5ml was pipetted out in to separate 100ml volumetric flask. 
Then the volume was made upto 100ml with methanol. The absorbance of 
each solution was found out at 344nm against a reagent blank. The readings 
are presented in Table- 35and graph-8      
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Table – 35
DATA FOR BEER’S LAW PLOT FOR MONTELUCAST
(Linearity)
S.No. Concentration μg/ml Absorption
1 50 0.0379
2 60 0.0448
3 70 0.0519
4 80 0.0598
5 90 0.0667
6 100 0.0742
7 110 0.0819
8 120 0.0896
9 130 0.0968
10 140 0.1049
11 150 0.1144
Linearity Co-efficient (γ )          =        0.9996
Slope (m)                                  =        0.0007566
Intercept (c)                               =        -0.0008
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DEVIATIONS FROM BEER’S LAW
          A system is said to obey Beer’s law, where a plot of concentration vs 
absorbance gives a straight line by using a line of best fit.  When a straight 
line is not obtained; the system is said to be deviated from Beer’s law. 
          For  the  drug  montelucast  maximum  deviation  was  found  in  the 
concentration range above 150μg/ml.  The readings are presented in Table 
-36 and graph-9.
Table-36 
DATA FOR DEVIATIONS FORM BEER’S LAW PLOT FOR 
MONTELUCAST
S.No. Concentration μg/ml Absorbance
1. 50 0.0379
2. 60 0.0448
3. 70 0.0519
4. 80 0.0598
5. 90 0.0667
6. 100 0.0742
7. 110 0.0819
8. 120 0.0896
9. 130 0.0968
10. 140 0.1049
11. 150 0.1144
12. 160 0.1264
13. 170 0.1278
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Determination of Absorption Maximum (λmax) for Theophylline
Procedure:
          100mg of authentic theophylline sample was accurately weighed and 
transferred to 50ml volumetric flask and methanol was added, dissolved and 
the volume was made upto 50ml with methanol.
                  5ml of this stock was pipetted out in to separate 100ml 
volumetric flask and the volume was made up to 100ml with methanol
          The  absorbance  of  solution  was measured  against  solvent  bank in 
UV-region  of  200-400  nm.   The  λ  max was  found  to  be  289nm.   This 
spectrum of maximum absorbance is shown in graph-10
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BEER’S LAW PLOT FOR THEOPHYLLINE
          The  intensity  of  a  beam  of  parallel  monochromatic  radiation 
decreases  exponentially  with  the  number  of  absorbing  molecules.  More 
simply it is stated that the absorbance is proportional to the concentration.
                               Log I0 / It =KC
       Beer’s law plot was constructed by measuring the absorbance of various 
concentration of drug against solvent blank.
PROCEDURE
          100mg of authentic Theophylline sample was accurately weighed and 
transferred to 50ml volumetric flask and methanol was added dissolved and 
the volume was made up to 50ml with methanol. 
          From this aliquots of 5ml, 5.5ml, 6ml, 6.5ml, 7ml, 7.5ml, 8ml, 8.5ml, 
9ml,  9.5ml,10ml was pipetted out in to separate  100ml volumetric  flask. 
Then the volume was made upto 100ml with methanol.  The absorbance of 
each solution was found out at 289nm against a reagent blank.  The readings 
are presented in Table-37 and graph-11
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TABLE-37
DATA FOR BEER’S LAW PLOT FOR THEOPHYLLINE
S.No. Concentration μg/ml Absorbance
1. 100 0.1702
2. 110 0.1872
3. 120 0.2064
4. 130 0.2263
5. 140 0.2382
6. 150 0.2598
7. 160 0.2768
8. 170 0.2949
9. 180 0.3146
10. 190 0.3278
11. 200 0.3488
Linearity coefficient γ = 0.9995
Slope (m)                    = 0.001778
Intercept (c)                   =0.0813
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DEVIATIONS FROM BEER’S LAW
          A system is said to obey Beer’s law, where a plot of concentration vs 
absorbance gives a straight line by using a line of best fit. When a straight 
line is not obtained; the system is said to be deviated from Beer’s law.
          For  the  drug,  Theophylline  maximum deviation  was  found  in  the 
concentration range above 200μg/ml. The readings are presented in Table – 
38 and graph-12 
Table – 38
Data for Deviations from Beer’s law plot for Theophylline
S.No. Concentration μg/ml Absorption
1 100 0.1702
2 110 0.1872
3 120 0.2064
4 130 0.2263
5 140 0.2382
6 150 0.2598
7 160 0.2768
8 170 0.2949
9 180 0.3146
10 190 0.3278
11 200 0.3488
12 210 0.3524
13 220 0.3568
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Preparation of montelucast standard solution
          100mg of authentic  montelucast  sample  is  accurately  weighed and 
transferred to 50ml volumetric flask and 5ml of methanol was added and 
shaken  until  it  dissolves  and  the  volume  was  made  upto  50ml  with 
methanol.
          From this 5ml was pipetted out in to separate 100ml volumetric flask 
and  the  volume  was  made  up  to  100ml  with  methanol  to  give  a 
concentration of 100μg/ml.
Preparation of Theophylline standard solution 
          100mg of authentic theophylline sample is accurately weighed and 
transferred to 50ml volumetric flask and 5ml of methanol was added and 
shaken  until  it  dissolves  and  the  volume  was  made  upto  50ml  with 
methanol.    
          From this 5ml was pipetted out in to separate 100ml volumetric flask 
and  the  volume  was  made  up  to  100ml  with  methanol  to  give  a 
concentration of 100μg/ml.
The  absorbance  &  absorptivity  values  are  shown  in  Table-  39a  &39b 
respectively.
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Preparation of sample solution
          Twenty tablets are weighed and average weight was calculated. The 
tablets  are  ground  to  a  fine  powder.  A  powder  equivalent  to  10mg  of 
montelucast  and  200mg  of  theophylline  was  accurately  weighed  and 
transferred to 50ml volumetric flask and 15ml of methanol was added and 
shaken  until  it  dissolves  and  the  volume  was  made  upto  50ml  with 
methanol. This solution was filtered through whatmann filter paper. 
          From this 5ml was pipetted out in to separate 100ml volumetric flask 
and the volume was made up to 100ml with methanol.
          The absorbance of  each solution was found out  at  344nm (λmax of 
montelucast) and 289nm (λmax of Theophylline) against a reagent blank. The 
analysis data are given in table-40
Calculation:
          λ1 = 289nm            λ2 = 344nm
ax1 and ax2 – Absorptivities of Theophylline at λ1 and λ2
ay1 and ay2 – Absorptivities of montelucast at λ1 and λ2 
Cx and Cy – Concentration of Theophylline and montelucast of
  sample respectively in grams / 100 ml.
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A1 and A2 – Absorbance of sample at λ1 and λ2    
Absorptivity (a) = A/bc = Absorbanceb x concentration of substance
Determination of Theophylline             
Cx = A2 ay1 – A1 ay2ax2 ay1 – ax1 ay2
Determination of montelucast
Cy = A1 ax2 – A2 ax1ax2 ay1 – ax1 ay2
Table-39a
Absorbance values for standard and sample
Wavelength Theophylline montelucast Sample
289 λ1 Theophylline 0.0742 (X1) 0.0246 (y1) 1.5204    (A1)
344 λ2 montelucast 0.0081  (X 2) 0.1702 (y2) 0.3354    (A2)
Table-39b
Absorptivity values for montelucast and theophylline
Parameter
Absorptivity at  289nm Absorptivity at 344nm
Theophylline Montelucast Theophylline Montelucast
*Mean ax1=74.26 ay1=24.66 ax2= 8.152 ay2=170.26
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Absorptivity values are the mean of six determinations. ax1 and ax2 
are absorptivities  of Theophylline at 289 nm, and 344nm, respectively; ay1 
and  ay2 are  abxorptivities  of   Montelucast    at  289nm  and  344nm 
respectively.
 
CRITERIA FOR OBTAINING MAXIMUM PRECISION
(A2 / A1)/ (ax2 / ax1)  and (ay2 / ay1)/ (A2 / A1) was found to be 2.00 & 31.29 
respectively.  This ratio should lie outside the range 0.1-2.0 for the precise 
determination.
Table-40
Analysis data of tablet formulations
Parameters
UV-spectrophotometry
Montelucast Theophylline
Label Claim 10mg 200mg
Amount found 9.986 mg 199.98mg
*% Drug content 99.86 199.98
        *value for % Drug content are mean of five estimations.
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RECOVERY STUDIES
          To  check the  accuracy  of  the  developed  method  and to  study  the 
interference of formulation additives, analytical recovery experiments were 
carried out by standard addition method at 80, 100 and 120% level. From 
the total amount of drug found the percentage recovery was calculated. The 
results are reported in Table-41.
TABLE-41
Recovery studies
Montelucast
Range Amount found Recovery
80% 9.985 mg 99.85%
100% 10.18 mg 100.09%
120% 9.982 mg 99.82%
Theophylline
Range Amount found Recovery
80% 199.98 mg 99.99%
100% 200.12mg 100.06%
120% 199.98mg 99.99%
                      *Recovery is the mean of three estimations
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SIMULTANEOUS UV SPECTROPHOTOMETRIC 
ESTIMATION OF MONTELUCAST AND 
THEOPHYLLINE  IN COMBINED TABLET DOSAGE 
FORM BY ABSORBANCE
RATIO METHOD
PRINCIPLE:
This  method depends on the property of  a  substance  which obeys 
Beer’s  law  at  all  wavelengths,  the  ratio  of  absorbance  at  any  two 
wavelengths is a constant value independent of concentration or path length. 
Two different dilutions of the same sample give the same absorbance ratio; 
this ratio is referred to as a ‘Q’ value.
Preparation of Montelucast standard solution
          100mg of authentic  montelucast  sample  is  accurately  weighed and 
transferred to 50ml volumetric flask and methanol was added and shaken 
until it dissolves and the volume was made upto 50ml with methanol.
          From this 5ml was pipetted out in to separate 100ml volumetric flask 
and the volume was made up to 100ml with methanol.
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Preparation of  Theophylline  standard solution 
          100mg of authentic theophylline sample is accurately weighed and 
transferred to 50ml volumetric flask and methanol was added and shaken 
until it dissolves and the volume was made upto 50ml with methanol.            
          From this 5ml was pipetted out in to separate 100ml volumetric flask 
and the volume was made up to 100ml with methanol.
The  absorbance  &  absorptivity  values  are  shown  in  table-42a  &  42b 
respectively.
Determination of Iso Absorptive point:
          The standard solutions of Montelucast and Theophylline are scanned 
over  200-400nm.  When  the  graph  was  plotted  with  wavelength  against 
absorbance, the wavelength of equal absorptivity was found at 302nm.   The 
overlain spectra is shown in figure-B
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Preparation of sample solution
          Twenty tablets are weighed and average weight was calculated. The 
tablets  are  ground  to  a  fine  powder.  A  powder  equivalent  to  10  mg 
Montelucast   and  200mg  of  Theophylline  was  accurately  weighed  and 
transferred to 50ml volumetric flask and methanol was added and shaken 
until it dissolves and the volume was made upto 50ml with methanol. This 
solution was filtered through whatmann filter paper. 
          From this 5ml was pipetted out in to separate 100ml volumetric flask 
and the volume was made up to 100ml with methanol.
          The absorbance of each solution was found out at 302 (Iso Absorptive 
point) and 344nm (λmax of montelucast) against a reagent blank.
The analysis value are given in table-43
132
Calculation:
          λ1 = 302nm (Iso absorpritive point)
          λ2 = 344nm (λmaxof montelucast)
ax1 and ax2 – Absorptivities of theophylline at λ1 and λ2
ay1 and ay2 – Absorptivities of montelucast at λ1 and λ2 
Cx and Cy – Concentration of theophylline and montelucast
  (Sample) in grams per 100ml
A1 and A2 – Absorbance of sample at λ1 and λ2    
Absorptivity (a) = A/bc = AbsorbanceB x concentration of substance
Determination of Cx and Cy
Cx = Qm – Qy x A1Qx - Qy Ax1
Cy = Qm – Qx x A1Qy - Qx Ax1
Where
Qm =
A2
A1
          
Qx =
Ax2
Ax1
Qy =
Ay2
Ay1
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Table-42a
Absorbance values for standard and sample
Wavelength Theophylline Montelucast Sample
302
λ1
Iso absorptive point
0.08014 0.08014 0.16946 (A1)
344
λ2
Montelucast
0.17026 0.00815 0.3354(A2)
Table-42b
Absorptivity values for Montelucast and Theophylline
Para-
meter
Absorptivity at  302nm Absorptivity at 344nm
Theophylline Montelucast Theophylline Montelucast
*Mean ax1=80.14 ay1=80.14 ax2= 8.152 ay2=170.26
*  Absorptivity values are the mean of six determinations.  ax1 and ax2 are 
absorptivities  of theophylline at 302nm, and 344nm, respectively; ay1 and 
ay2 are absorptivities of montelucast  at 302nm and 344nm repectively.
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Table-43
Analysis data of tablet formulations
Parameters
UV-spectrophotometry
Montelucast Theophylline
Label Claim 10mg 200mg
Amount found 99.80% 99.94%
*% Drug content 9.982mg 199.88mg
*value for % Drug content are mean of five estimations
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RECOVERY STUDIES
          To  check the  accuracy  of  the  developed  method  and to  study  the 
interference of formulation additives, analytical recovery experiments were 
carried out by standard addition method at 80, 100 and 120% level. From 
the total amount of drug found the percentage recovery was calculated. The 
results are reported in Table-10.
Table-44
Recovery studies
Montelucast
Range Amount found Recovery
80% 9.985mg 99.85%
100% 10.10mg 101.00%
120% 9.86mg 99.86%
Theophylline
Range Amount 
found
Recovery
80% 199.98mg 99.99%
100% 200.20mg 100.10%
120% 199.98mg 99.99%
                       *Recovery is the mean of three estimations
136
SIMLULTANIOUS ESTIMATION OF MONTELUCAST 
AND THEOPHYLLINE IN TABLETS BY HPTLC
1. Selection and pre washing of plate:
          A precoated  silica gel 60 f254 on aluminium sheet with 100 to 250 
micro m thickness was selected for study . Pre washing of plate was done 
with methanol and then it was activated by keeping in an oven at 115° for 10 
mts.
2. Selection of  Solvent:
Ideal property of a solvents employed fo HPTLC are,
• Drugs should be soluble in the solvent used  
• Drug should show stability in the solvent used.  
• Drug should be stable.  
• Solvent should be volatile.  
Accordingly methanol is selected as the solvent of sample for further 
studies.
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3. Selection of wave length 
          UV spectra of montelucast and theophylline was found the λmax of 
montelucast and theophylline was found to be 289nm and 344 nm. Wave 
length of 254nm was selected for the study.
4. Development of Optimum Mobile Phase:
          A  solvent  system  that  would  give  dense  compact  spots,  good 
separation of both drugs from each other and separation from solvent front 
and application position was to be selected. Initially different solvent system 
were tried as below.
Mobile phase Observation
n-hexane: Methanol:Glacial acetic acid No good separation
Toluene: Acetone:Methanol No movement of theophylline
Chloroform:Ethyl acetate :Methanol No good separation
Ethyl acetate: Methanol Seperation was poor
Toluene:Ethyl acetate :acetone:Formic 
acid
Both the drugs moves along 
with solvent front
Ethyl 
acetate:Chloroform:Ethanol:Ammonia
Good separation
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In  the  above  system  (except  Ethyl  acetate:  Chloroform:  Ethanol: 
Ammonia) either the analytes  ran along with the solvent front or did not run 
or tailing was absorbed. That is the resolution was very poor.
Optimization of mobile phase (Ethyl acetate: 
Chloroform:Ethanol:Ammonia)
                       Different ratios of Ethyl acetate:chloroform:ethanol:ammonia  
were tried in order to achive an optimum resolution with good peak and 
sharper  of  both  drugs.  A  ratio  of  Ethylacetate:  Chloroform:  Ethanol: 
Ammonia (6:4:3:1) was selected because it gave compact spots and good 
resolution  between  analytes  and  good  separation  from solvent  front  and 
sample application position. The trail chromatograms for this mobile phase 
system are shown in the chromatograms.
Instrument:
 C  AMAG TLC scanner-3  
 Millipore filter (10-45/um)  
 Whatmann filter paper  
 Sonicator.  
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Reagents and chemicals:
          Ethyl acetate 
          Chloroform
          Ethanol
          Ammonia
Reference standard:
          Motelucast
          Theophylline.
Sample brand used:
ZOMONT-THEO   (Panacea biotech)
Label claim:
            Montelucast-10mg
 Theophylline -200mg.
Fixed chromatographic conditions:
          Instrument :         Camag TLC scanner 3.
          Test plate   :         Precoated plates silica gel 60 f254 aluminium.
          Format       :         8x7cm
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          Thickness             :         200µm
Spotting volume  :         2-10µl
Amount / spot
          Montelucast –0.02-0.1µl
          Theophylline – 0.4 -2µl.
Mobile phase:     Ethylacetate:Chloroform:Ethanol:Ammonia (6:4:3:1)
Speration technique : Ascending
          Detection    :  UV
          Wavelength: 254nm.
Quantitative determination of drugs by using the developed method:
Sample: ZOMONT-THEO (Panacea biotech)
Label claim:
          Montelucast        -          10mg
          Theophylline`     -         200mg
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Preparation of standard solution:
Weigh  accurately  about  10mg  of  montelucast  and  200mg  of 
theophylline into a 100ml volumetric flask. The powder was first dissolved 
in 25ml of  methanol  and sonicated for  few minutes and filtered through 
what  man  filter  paper.  Finally  the  volume  was  adjusted  to  100ml  with 
methanol. Form this solution 5ml was transferred to 50ml volumetric flask 
and the volume was adjusted to 50ml with methanol.
Preparation of sample solution:
          20  tablets  were  weighed  and  powdered  .Average  weight  of 
(1.142g) sample tablet Zomont-theo (equivalent to 10mg of montelucast and 
200mg of theophylline ) was taken into a 100ml volumetric flask, the power 
was first dissolved in 25ml of methanol and sonicated for few minutes and 
filtered through whatman filter paper. Finally the volume was adjusted to 
100ml  with  methanol.  From  this  solution  5ml  was  transferred  to  50ml 
volumetric flask and the volume  was adjusted to 50ml with methanol to get 
concentration of 10mg of montelucast and 200mg of theophylline.
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Method:
4µl of this standard and sample solution was spotted over the TLC 
plate  and  it  was  placed  on  the  saturated  solvent  chamber  containing  a 
mobile  phases(Ethyacetate:Chloroform:  Ethanol:  Ammonia)(6:4:3:1) 
system and allowed to develop the solvent.
After the solvent has traveled to a distance of 7cm, the plates were 
removed form the chamber and dried. The components were detected by 
examination under UV detection.
After the detection of spots, the TLC plates were placed on the TLC 
scanner  and set  the  x  axis  and y  axis  value  by adjusting  light  of    the 
deuterium lamp  fallen  just  below the  spot  after  the  scanning  lamp  was 
completed the chromatogram was recorded and it is shown in figure
Amount of drug present in the tablet
Sample area               standard dilution           potency      
_____________ x _______________    x_________  x   avg.weight
Standard area           sample dilution               100
Percentage purity            =     amount present
                                                ____________   x  100
                                                Label claim
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Table:45
                             Quantitative  estimation
Brand name content Label 
claim
Peak 
area
Amount 
present(mg)
Percentage 
purity%w/w
ZOMONT-
THEO
Montelucast 10mg 622.6 10.13mg 101.33
Theophylline 200mg 2375.0 199.82mg 99.91
Acceptance criteria:98-102%
Assay of montelucast:
622.6           11.8             99.8
_____x        _____x        _____ x 1.142       10.13mg
762.1           1.0842                   100
 
%label claim = 10.13      
                              _____x100
                                         10
                                =   101.33%
Assay of theophylline:
    2375                  205.7           99.87
    _____x              _____x        _____x1.142
    2570.0               1.0842                   100
Label claim = 199.82
                    _____x100=99.91%
                    200
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                                                Validation
The  word validation means assessment of validity action of proving 
effectiveness. Validation of an analytical method is a process to establish by 
laboratory studies that the performance characteristics of the method meet 
the  requirement  for  the  intended  analytical  application  performance. 
Characteristics are expressed in terms of analytical parameters.
Design of experiment:
          Typical analytical parameters used in assay validation are:
• linearity and range  
• limit of quantitation  
• limit of detection  
• accuracy  
• stability  
Linearity and  Range:
          Linearity of an analytical procedure is its ability to obtain test results 
which are directly proportional to the concentration of analyte in the sample 
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Preparation of montelucast standard solution:
10mg  of  standard  montelucast  was  weighed  accurately  and 
transferred to 100ml volumetric flask. Add 25ml of methanol to dissolve the 
drug and the volume is made upto 100ml with menthol.
          From the resulting solution 3ml, 4ml, 5ml, 6ml 7ml were transferred 
into  five  different  50ml  volumetric  flask.  The  volume  was  made  with 
methanol to get a final concentration of 6, 8 ,10 12, 14µg/ ml. 4µl of the 
resulting  solution  was  injected  and  chromatogram  was  recorded.The 
chromatogram was shown in figure 
Preparation of theophylline standard solution:
200mg  of  standard  montelucast  was  weighed  accurately  and 
transferred to 100ml volumetric flask add 25ml of methanol to dissolve the 
drug. And the volume is made upto 100ml with menthol.
          From  the  resulting  solution  4ml,  4.5ml,  5ml,  5.5ml  6ml  were 
transferred into five different 50ml volumetric flask. The volume was made 
with methanol to get a final concentration of 100mg ,150mg, 200mg,250mg, 
300mg. 4µl of the resulting solution was injected and chromatogram was 
recorded. The chromatogram was shown in figure 
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Acceptance criteria:
      Correlation coefficient should not be less than 0.99.The  linearity data 
and analytical performance parameters of monlelucast, and theophylline are 
shown in table   and calibration curve are shown in graph.
                                                   Table-46
                                         Linearity data
Montelucast
S. No. concentration
(mglml)
Area obtained
1. 6 624.9
2. 8 756.3
3. 10 1078.1
4. 12 1187.1
5. 14 1256.3
Table-47
Theophylline
S.No concentration mg/ml area obtained
1. 100 769.2
2. 150 961.9
3. 200 1154.6
4. 250 1384.3
5. 300 1648.9
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Table-48
Analytical Performance Parameters:
S. No Drug name
Linearity 
range
(µ g/ml)
Correlation
Coefficient(γ
)
Slope Intercept
1. Montelucast 6-14 0.9962 79.23 310.858
2. Theophyllin
e
100-300 0.9974 4.3636 128.36
Limit of detection(L.O.D)
          It is lowest amount of analyte in a sample that can be detected but not 
necessarily  quantities  as  an  exact  value  under   the  stated  experimental 
conditions. The detection limit is usually expressed as the concentration of 
analyte .
It is given  by
DL= 
3.3
S
σ
σ  - standard deviation of the  response 
M - slope of the calibration curve.
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Table-49
                                  Limit of detection.
Drug Standard 
Deviation
Slope L.O.D
mglml
Monlelucast 3.162 79.23 0.131
Theophylline. 79.05 4.3636 59.782
Limit of quantitation:
          The quantitation limit of an analytical procedure is the lowest amount 
of analyte which can be  quantitatively determined with suitable precision 
and accuracy.
It is given by.
                              
QL= 
10
S
σ
   
                                       σ=  standard deviation of the response.
                                         M  = slope of the calibration curve
                         
149
Table-50
             Limit of quantitation
Drug Standard deviation Slope L.O.Q mg/ml
Montelucast 3.162 79.23 0.399
Theophyllin
e
79.05 4.3636 181.157
ACCURACY:
          The accuracy of an analytical procedure express the closeness of the 
measured value to the true value for the sample.
          Accuracy may often be expressed as percent  recovery by the assay of 
know added amount of analyte.
Determination:
          The  accuracy of the analytical method  was determined by applying 
the method to the analysed samples to which known amounts of 
acceptance criteria.Percentage recovery should be within 98- 102% w/w.
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TABLE-41
Recovery studies
Montelucast
Range Amount found Recovery
80%        10.15           101.53%
100%        10.23 mg           102.36%
120%        10.13 mg            101.33%
Theophylline
Range Amount found Recovery
80%       200.22 mg         100.11%
100%       197.63mg        98.81%
120%        199.82mg         99.91%
Stability studies :
When the developed chromatographic plate is exposed to atmosphere 
the analytes are likely to be decomposed hence it is necessary to conduct 
stability studies. Stability of the analyte on plate was studied at different 
time  intervals  and  peak areas  are  were  compared  with  the  peak  area  of 
freshly scanned plate the developed plate was found to be 2 hours and 3 
hours for montelucast and theophylline. 
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RESULTS AND DISCUSSION
Ofloxacin and nitazoxanide:
          UV spectrophotometry  and  reverse  phase  high  performance  liquid 
chromatography were developed for analysing  ofloxacin and nitazoxanide 
in combined tablet dosage form.
          For  UV  spectrophotometry  simultaneous  equation  and  absorbance 
ratio method was carried out. Linearity was obtained in the concentration 
range of 5 to 50 μg/ml for both drugs. In simultaneous equation method the 
% Drug content was found to be 99.97% and 100.31% . In absorbance ratio 
method  the  %  drug  content  was  found  to  be  100.67%  and  100.27%. 
Recovery experiments were performed and it was within 98 – 102% .
          In  HPLC  method,  HPLC  conditions  were  optimized  to  obtain  an 
adequate  separation  of  eluted  compounds.  Initially  various  mobile  phase 
were  tried,  to  separate  drugs.  Mobile  phase  and flow rate  selection  was 
based  on  peak  parameters  (height,  tailing,  theoretical  plates,  etc).  The 
system with buffer (Tetra butyl ammonium hydrogen sulphate): methanol 
Acetonitrile (20:20:60:v/v) with 0.5 ml/min flow rate is quite robust. The 
optimum  wavelength  for  detection  was  280nm  at  which  better  detector 
response for drugs was obtained. The average retention times for ofloxacin 
and nitazoxanide is 4.67min and 7.77 min respectively.
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According  to  USP  system  suitability  test  are  an  integral  part  of 
chromatographic method. They are used to verify the reproducibility of the 
chromatographic system. To ascertain its  effectiveness,  system suitability 
tests were carried out on freshly prepared stock solution. The parameters are 
shown in table 41.
          The calibration curve was found to be linear for both ofloxacin &
Nitazoxanide.The percentage purity was 100.20 %and 99.94% for ofloxacin 
and nitazoxanide  respectively.
          The mean recoveries were found to be in the range of 98% to 102%.
          Limit  of  detection for  ofloxacin and nitazoxanide was found to be 
2.040 μg/ml & 0.0000431μg/ml respectively.
          Limit of quantitation for ofloxacin & nitazoxanide was found to be 
6.183 μg/ml & 0.0001306 μg/ml respectively.
Robustness of the proposed method was determined by changing the 
wavelength and flow rate.
Ruggedness  of  proposed  method  was  determined  by  analysis  of 
aliquots from homogenous slot by different analyst in different days using 
similar  operational  environmental  condition.  The results  were within 98-
102%.
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Montelucast and Theophylline:
Montelucast  and  theophylline  in  combined  dosage  form  was 
estimated  by  UV  spectrophotometry  and  high  performance  thin  layer 
chromatography.
          In UV both simultaneous and absorbance ratio method was carried 
out.  Linearity  was  obtained  in  the  concentration  range  of  50  μg/ml  to 
150 μg/ml for montelucast and 100 μg/ml to 200 μg/ml for theophylline.
          The percentage drug content was found to 99.86% and 99.99% for 
montelucast  and  theophylline  respectively  using  simultaneous  equation 
method.
          The  percentage  drug  content  using  absorbance  ratio  method  was 
found to be 99.94 and 99.80 for montelucast and theophylline  respectively.
          The  recovery  experiments  were  also  performed  for  both  method 
which was within the range of 98-102%.
                In HPTLC method, HPTLC conditions were optimized to obtain 
an adequate separation of eluted compounds. Initially various mobile phase 
were tried, to separate drugs. Mobile phase was selected depending upon the 
separation  of  the  combined  drugs.  The  Mobile  phase  of  Ethyl 
acetate:chloroform:ethanol:ammonia(6:4:3:1)  was  selected.  The  optimum 
wavelength for detection was 254nm at which better detector response for 
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drugs was obtained. The average Rf values for montelucast and theophylline 
and  min respectively.
          The calibration curve was found to be linear for both montelucast & 
theophylline.The  percentage  purity  was  101.33%  and  99.91%  for 
montelucast and theophylline  respectively.
          The mean recoveries were found to be in the range of 98% to 102%.
          Accuracy was found at  80%, 100%, 120% level.They were found to 
be in the range of 98-102% level.        
           Limit of detection for montelucast and theophylline was found to be  
0.131 μg/ml &59.78 μg/ml respectively.
          Limit of quantitation for montelucast & theophylline was found to be 
0.399 μg/ml & 181.75 μg/ml respectively.
Stability  studies  was  also  carried  out  to  check the  stability  of  the 
plates and decomposition of the drugs after a specified time. 
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SUMMARY AND CONCLUSION
          Ofloxacin and Nitazoxanide available in combined tablet dosage form 
were  analysed  by  UV–spectrophotometric  simultaneous  equation  and 
absorbance  ratio  method  and  reverse  phase  high  performance  liquid 
chromatography.
          On comparing these methods reverse phase high performance liquid 
chromatography was found to be more accurate, simple, and rapid than UV 
spectrophotometric\methods.
          Montelucast  and theophylline in combined tablet  dosage form was 
estimated  using  High  performance  thin  layer  chromatography  and  UV- 
spectophotometry employing simultaneous equation method and absorbance 
ratio method.
          On  comparing  these  methods  High  performance  thin  layer 
chromatography was found to be more accurate ,simple and rapid than UV 
spectrophotometry methods.            
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